{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:10:34Z","timestamp":1789013434881,"version":"build-2803163510"},"reference-count":371,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Polish Ministry of Science and Higher Education","award":["N41\/DBS\/001623"],"award-info":[{"award-number":["N41\/DBS\/001623"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"DOI":"10.1007\/s12016-026-09202-1","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:56:42Z","timestamp":1789012602000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Molecular Signature and miRNA Pattern of CD4\u2009+\u2009T Lymphocytes in Plaque Psoriasis"],"prefix":"10.1007","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-2390-8269","authenticated-orcid":false,"given":"Yelyzaveta","family":"Dubna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1302-117X","authenticated-orcid":false,"given":"Katarzyna","family":"Nazimek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"9202_CR1","doi-asserted-by":"publisher","first-page":"5306","DOI":"10.3390\/ijms25105306","volume":"25","author":"K Nazimek","year":"2024","unstructured":"Nazimek K, Bryniarski K (2024) Macrophage Functions in Psoriasis: Lessons from Mouse Models. Int J Mol Sci 25:5306. https:\/\/doi.org\/10.3390\/ijms25105306","journal-title":"Int J Mol Sci"},{"key":"9202_CR2","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41572-025-00630-5","volume":"11","author":"AW Armstrong","year":"2025","unstructured":"Armstrong AW, Blauvelt A, Callis Duffin K et al (2025) Psoriasis. Nat Rev Dis Primers 11:45. https:\/\/doi.org\/10.1038\/s41572-025-00630-5","journal-title":"Nat Rev Dis Primers"},{"key":"9202_CR3","doi-asserted-by":"publisher","first-page":"1714515","DOI":"10.3389\/fimmu.2026.1714515","volume":"17","author":"B Wang","year":"2026","unstructured":"Wang B, Zhang Y, Lin L et al (2026) Psoriasis: microbiome dysbiosis and pathogenic mechanisms. Front Immunol 17:1714515. https:\/\/doi.org\/10.3389\/fimmu.2026.1714515","journal-title":"Front Immunol"},{"key":"9202_CR4","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41423-020-0519-3","volume":"18","author":"R Uppala","year":"2021","unstructured":"Uppala R, Tsoi LC, Harms PW et al (2021) Autoinflammatory psoriasis-genetics and biology of pustular psoriasis. Cell Mol Immunol 18:307\u2013317. https:\/\/doi.org\/10.1038\/s41423-020-0519-3","journal-title":"Cell Mol Immunol"},{"key":"9202_CR5","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.3390\/ijms20061475","volume":"20","author":"A Rendon","year":"2019","unstructured":"Rendon A, Sch\u00e4kel K (2019) Psoriasis Pathogenesis and Treatment. Int J Mol Sci 20:1475. https:\/\/doi.org\/10.3390\/ijms20061475","journal-title":"Int J Mol Sci"},{"key":"9202_CR6","doi-asserted-by":"publisher","first-page":"1830099","DOI":"10.3389\/fimmu.2026.1830099","volume":"17","author":"J Ma","year":"2026","unstructured":"Ma J, Li H, Yang X et al (2026) Psoriasis as a systemic inflammatory disease: an immune set-point framework for comorbidities and relapse. Front Immunol 17:1830099. https:\/\/doi.org\/10.3389\/fimmu.2026.1830099","journal-title":"Front Immunol"},{"key":"9202_CR7","doi-asserted-by":"publisher","first-page":"4353","DOI":"10.3390\/jcm15114353","volume":"15","author":"G \u017daliukait\u0117","year":"2026","unstructured":"\u017daliukait\u0117 G, Raudonis T (2026) The Impact of Biologic Therapy on Quality of Life and Mental Health in Patients with Psoriasis. J Clin Med 15:4353. https:\/\/doi.org\/10.3390\/jcm15114353","journal-title":"J Clin Med"},{"key":"9202_CR8","doi-asserted-by":"publisher","first-page":"e8964","DOI":"10.7759\/cureus.8964","volume":"12","author":"VM Awad","year":"2020","unstructured":"Awad VM, Sakhamuru S, Kambampati S et al (2020) Mechanisms of Beta-Blocker Induced Psoriasis, and Psoriasis De Novo at the Cellular Level. Cureus 12:e8964. https:\/\/doi.org\/10.7759\/cureus.8964","journal-title":"Cureus"},{"key":"9202_CR9","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2147\/PTT.S126727","volume":"7","author":"DM Balak","year":"2017","unstructured":"Balak DM, Hajdarbegovic E (2017) Drug-induced psoriasis: clinical perspectives. Psoriasis (Auckl) 7:87\u201394. https:\/\/doi.org\/10.2147\/PTT.S126727","journal-title":"Psoriasis (Auckl)"},{"key":"9202_CR10","doi-asserted-by":"publisher","first-page":"1711288","DOI":"10.3389\/fmicb.2025.1711288","volume":"16","author":"J Chen","year":"2025","unstructured":"Chen J, Sun K, Zhang X et al (2025) Psoriasis and gut microbes: research advances from mechanism to therapy. Front Microbiol 16:1711288. https:\/\/doi.org\/10.3389\/fmicb.2025.1711288","journal-title":"Front Microbiol"},{"key":"9202_CR11","doi-asserted-by":"publisher","first-page":"4656","DOI":"10.3390\/ijms27114656","volume":"27","author":"MC Gama de Souza Silva","year":"2026","unstructured":"Gama de Souza Silva MC, De Pietro L, Cataldo CRS et al (2026) Beyond Inflammation: The Role of Oxidative Stress and Gut-Skin Axis Dysbiosis in the Pathogenesis of Immune-Mediated Skin Disorders and Potential Therapeutic Implications. Int J Mol Sci 27:4656. https:\/\/doi.org\/10.3390\/ijms27114656","journal-title":"Int J Mol Sci"},{"key":"9202_CR12","doi-asserted-by":"publisher","unstructured":"Kent J, Chao J, Liao W, Singla S (2026) Exploring the Gut Microbiome\u2019s Association in Psoriasis and Psoriatic Arthritis: A Scoping Review. J Psoriasis Psoriatic Arthritis 24755303261464171. https:\/\/doi.org\/10.1177\/24755303261464171","DOI":"10.1177\/24755303261464171"},{"key":"9202_CR13","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","volume":"397","author":"CEM Griffiths","year":"2021","unstructured":"Griffiths CEM, Armstrong AW, Gudjonsson JE, Barker JNWN (2021) Psoriasis Lancet 397:1301\u20131315. https:\/\/doi.org\/10.1016\/S0140-6736(20)32549-6","journal-title":"Psoriasis Lancet"},{"key":"9202_CR14","doi-asserted-by":"publisher","first-page":"e10247","DOI":"10.1371\/journal.pone.0010247","volume":"5","author":"M Su\u00e1rez-Fari\u00f1as","year":"2010","unstructured":"Su\u00e1rez-Fari\u00f1as M, Lowes MA, Zaba LC, Krueger JG (2010) Evaluation of the psoriasis transcriptome across different studies by gene set enrichment analysis (GSEA). PLoS ONE 5:e10247. https:\/\/doi.org\/10.1371\/journal.pone.0010247","journal-title":"PLoS ONE"},{"key":"9202_CR15","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.3389\/fimmu.2018.01488","volume":"9","author":"C De Jes\u00fas-Gil","year":"2018","unstructured":"De Jes\u00fas-Gil C, Ruiz-Romeu E, Ferran M et al (2018) CLA\u2009+\u2009T Cell Response to Microbes in Psoriasis. Front Immunol 9:1488. https:\/\/doi.org\/10.3389\/fimmu.2018.01488","journal-title":"Front Immunol"},{"key":"9202_CR16","doi-asserted-by":"publisher","first-page":"e0196635","DOI":"10.1371\/journal.pone.0196635","volume":"13","author":"Y Lin","year":"2018","unstructured":"Lin Y, Liu L, Sheng Y et al (2018) A catalog of potential putative functional variants in psoriasis genome-wide association regions. PLoS ONE 13:e0196635. https:\/\/doi.org\/10.1371\/journal.pone.0196635","journal-title":"PLoS ONE"},{"key":"9202_CR17","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41540-025-00498-x","volume":"11","author":"B Mishra","year":"2025","unstructured":"Mishra B, Gou Y, Tan Z et al (2025) Integrative systems biology framework discovers common gene regulatory signatures in mechanistically distinct inflammatory skin diseases. NPJ Syst Biol Appl 11:21. https:\/\/doi.org\/10.1038\/s41540-025-00498-x","journal-title":"NPJ Syst Biol Appl"},{"key":"9202_CR18","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/ng.2827","volume":"46","author":"H Tang","year":"2014","unstructured":"Tang H, Jin X, Li Y et al (2014) A large-scale screen for coding variants predisposing to psoriasis. Nat Genet 46:45\u201350. https:\/\/doi.org\/10.1038\/ng.2827","journal-title":"Nat Genet"},{"key":"9202_CR19","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1038\/ng.2467","volume":"44","author":"LC Tsoi","year":"2012","unstructured":"Tsoi LC, Spain SL, Knight J et al (2012) Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nat Genet 44:1341\u20131348. https:\/\/doi.org\/10.1038\/ng.2467","journal-title":"Nat Genet"},{"key":"9202_CR20","doi-asserted-by":"publisher","unstructured":"Genetic Analysis of Psoriasis Consortium & the Wellcome Trust Case Control Consortium 2, Strange A, Capon F et al (2010) A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat Genet 42:985\u2013990. https:\/\/doi.org\/10.1038\/ng.694","DOI":"10.1038\/ng.694"},{"key":"9202_CR21","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1093\/pcmedi\/pbz011","volume":"2","author":"D Ran","year":"2019","unstructured":"Ran D, Cai M, Zhang X (2019) Genetics of psoriasis: a basis for precision medicine. Precis Clin Med 2:120\u2013130. https:\/\/doi.org\/10.1093\/pcmedi\/pbz011","journal-title":"Precis Clin Med"},{"key":"9202_CR22","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1084\/jem.20090480","volume":"206","author":"D Ganguly","year":"2009","unstructured":"Ganguly D, Chamilos G, Lande R et al (2009) Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8. J Exp Med 206:1983\u20131994. https:\/\/doi.org\/10.1084\/jem.20090480","journal-title":"J Exp Med"},{"key":"9202_CR23","doi-asserted-by":"publisher","first-page":"e70527","DOI":"10.1111\/acel.70527","volume":"25","author":"C Liu","year":"2026","unstructured":"Liu C, Yang M, Xiao F, Zeng J (2026) T Cell Immunosenescence in Inflammatory Skin Diseases: Pathogenesis and Therapeutic Targets. Aging Cell 25:e70527. https:\/\/doi.org\/10.1111\/acel.70527","journal-title":"Aging Cell"},{"key":"9202_CR24","doi-asserted-by":"publisher","first-page":"7553","DOI":"10.1038\/s41598-017-07975-2","volume":"7","author":"L \u0160ahmatova","year":"2017","unstructured":"\u0160ahmatova L, S\u00fcgis E, \u0160unina M et al (2017) Signs of innate immune activation and premature immunosenescence in psoriasis patients. Sci Rep 7:7553. https:\/\/doi.org\/10.1038\/s41598-017-07975-2","journal-title":"Sci Rep"},{"key":"9202_CR25","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s41572-021-00293-y","volume":"7","author":"O FitzGerald","year":"2021","unstructured":"FitzGerald O, Ogdie A, Chandran V et al (2021) Psoriatic arthritis. Nat Rev Dis Primers 7:59. https:\/\/doi.org\/10.1038\/s41572-021-00293-y","journal-title":"Nat Rev Dis Primers"},{"key":"9202_CR26","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.70561","author":"F Khoda","year":"2026","unstructured":"Khoda F, Khan Y, Haw WWY et al (2026) Prognostic prediction models for psoriatic arthritis in psoriasis: A systematic review. J Eur Acad Dermatol Venereol. https:\/\/doi.org\/10.1111\/jdv.70561","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"9202_CR27","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1600-0625.2011.01261.x","volume":"20","author":"W-H Boehncke","year":"2011","unstructured":"Boehncke W-H, Boehncke S, Tobin A-M, Kirby B (2011) The psoriatic march: a concept of how severe psoriasis may drive cardiovascular comorbidity. Exp Dermatol 20:303\u2013307. https:\/\/doi.org\/10.1111\/j.1600-0625.2011.01261.x","journal-title":"Exp Dermatol"},{"key":"9202_CR28","doi-asserted-by":"publisher","first-page":"2673285","DOI":"10.1080\/09546634.2026.2673285","volume":"37","author":"P Gisondi","year":"2026","unstructured":"Gisondi P, Fratton Z, Vighi da Rosa R et al (2026) Unveiling the IL-17 axis: an immunometabolic bridge between psoriasis and metabolic syndrome. J Dermatolog Treat 37:2673285. https:\/\/doi.org\/10.1080\/09546634.2026.2673285","journal-title":"J Dermatolog Treat"},{"key":"9202_CR29","doi-asserted-by":"publisher","first-page":"1790531","DOI":"10.3389\/fimmu.2026.1790531","volume":"17","author":"I Vahav","year":"2026","unstructured":"Vahav I, Thon M, Koning JJ et al (2026) CD4\u2009+\u2009and CD8\u2009+\u2009T cells contribute to psoriasis phenotype when integrated into human skin equivalents for drug testing. Front Immunol 17:1790531. https:\/\/doi.org\/10.3389\/fimmu.2026.1790531","journal-title":"Front Immunol"},{"key":"9202_CR30","doi-asserted-by":"publisher","first-page":"7960","DOI":"10.3390\/ijms25147960","volume":"25","author":"J Chojnacka-Purpurowicz","year":"2024","unstructured":"Chojnacka-Purpurowicz J, Owczarczyk-Saczonek A, Nedoszytko B (2024) The Role of Gamma Delta T Lymphocytes in Physiological and Pathological Condition-Focus on Psoriasis, Atopic Dermatitis, Autoimmune Disorders, Cancer and Lymphomas. Int J Mol Sci 25:7960. https:\/\/doi.org\/10.3390\/ijms25147960","journal-title":"Int J Mol Sci"},{"key":"9202_CR31","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/imr.12913","volume":"298","author":"MH Jee","year":"2020","unstructured":"Jee MH, Mraz V, Geisler C, Bonefeld CM (2020) \u03b3\u03b4 T cells and inflammatory skin diseases. Immunol Rev 298:61\u201373. https:\/\/doi.org\/10.1111\/imr.12913","journal-title":"Immunol Rev"},{"key":"9202_CR32","doi-asserted-by":"publisher","first-page":"627139","DOI":"10.3389\/fimmu.2021.627139","volume":"12","author":"C Qi","year":"2021","unstructured":"Qi C, Wang Y, Li P, Zhao J (2021) Gamma Delta T Cells and Their Pathogenic Role in Psoriasis. Front Immunol 12:627139. https:\/\/doi.org\/10.3389\/fimmu.2021.627139","journal-title":"Front Immunol"},{"key":"9202_CR33","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3389\/fimmu.2015.00020","volume":"6","author":"B Garcill\u00e1n","year":"2015","unstructured":"Garcill\u00e1n B, Marin AVM, Jim\u00e9nez-Reinoso A et al (2015) \u03b3\u03b4 T Lymphocytes in the Diagnosis of Human T Cell Receptor Immunodeficiencies. Front Immunol 6:20. https:\/\/doi.org\/10.3389\/fimmu.2015.00020","journal-title":"Front Immunol"},{"key":"9202_CR34","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3390\/ijms22010073","volume":"22","author":"DSM Chatzileontiadou","year":"2020","unstructured":"Chatzileontiadou DSM, Sloane H, Nguyen AT et al (2020) The Many Faces of CD4\u2009+\u2009T Cells: Immunological and Structural Characteristics. Int J Mol Sci 22:73. https:\/\/doi.org\/10.3390\/ijms22010073","journal-title":"Int J Mol Sci"},{"key":"9202_CR35","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1038\/mt.2012.71","volume":"20","author":"G Andolfi","year":"2012","unstructured":"Andolfi G, Fousteri G, Rossetti M et al (2012) Enforced IL-10 expression confers type 1 regulatory T cell (Tr1) phenotype and function to human CD4(+) T cells. Mol Ther 20:1778\u20131790. https:\/\/doi.org\/10.1038\/mt.2012.71","journal-title":"Mol Ther"},{"key":"9202_CR36","doi-asserted-by":"publisher","first-page":"1032575","DOI":"10.3389\/fimmu.2022.1032575","volume":"13","author":"RA Freeborn","year":"2022","unstructured":"Freeborn RA, Strubbe S, Roncarolo MG (2022) Type 1 regulatory T cell-mediated tolerance in health and disease. Front Immunol 13:1032575. https:\/\/doi.org\/10.3389\/fimmu.2022.1032575","journal-title":"Front Immunol"},{"key":"9202_CR37","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1016\/j.jid.2018.05.021","volume":"138","author":"J Kim","year":"2018","unstructured":"Kim J, Lee J, Gonzalez J et al (2018) Proportion of CD4\u2009+\u2009CD49b\u2009+\u2009LAG-3\u2009+\u2009Type 1 Regulatory T Cells in the Blood of Psoriasis Patients Inversely Correlates with Psoriasis Area and Severity Index. J Invest Dermatol 138:2669\u20132672. https:\/\/doi.org\/10.1016\/j.jid.2018.05.021","journal-title":"J Invest Dermatol"},{"key":"9202_CR38","doi-asserted-by":"publisher","first-page":"1005115","DOI":"10.3389\/fimmu.2022.1005115","volume":"13","author":"J Kim","year":"2022","unstructured":"Kim J, Moreno A, Krueger JG (2022) The imbalance between Type 17 T-cells and regulatory immune cell subsets in psoriasis vulgaris. Front Immunol 13:1005115. https:\/\/doi.org\/10.3389\/fimmu.2022.1005115","journal-title":"Front Immunol"},{"key":"9202_CR39","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.molimm.2012.03.025","volume":"51","author":"LL Jones","year":"2012","unstructured":"Jones LL, Chaturvedi V, Uyttenhove C et al (2012) Distinct subunit pairing criteria within the heterodimeric IL-12 cytokine family. Mol Immunol 51:234\u2013244. https:\/\/doi.org\/10.1016\/j.molimm.2012.03.025","journal-title":"Mol Immunol"},{"key":"9202_CR40","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.smim.2011.08.003","volume":"23","author":"C Pot","year":"2011","unstructured":"Pot C, Apetoh L, Awasthi A, Kuchroo VK (2011) Induction of regulatory Tr1 cells and inhibition of T(H)17 cells by IL-27. Semin Immunol 23:438\u2013445. https:\/\/doi.org\/10.1016\/j.smim.2011.08.003","journal-title":"Semin Immunol"},{"key":"9202_CR41","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/s41423-019-0220-6","volume":"16","author":"J Saravia","year":"2019","unstructured":"Saravia J, Chapman NM, Chi H (2019) Helper T cell differentiation. Cell Mol Immunol 16:634\u2013643. https:\/\/doi.org\/10.1038\/s41423-019-0220-6","journal-title":"Cell Mol Immunol"},{"key":"9202_CR42","doi-asserted-by":"publisher","first-page":"17675","DOI":"10.1038\/s41598-019-53240-z","volume":"9","author":"AK Kannan","year":"2019","unstructured":"Kannan AK, Su Z, Gauvin DM et al (2019) IL-23 induces regulatory T cell plasticity with implications for inflammatory skin diseases. Sci Rep 9:17675. https:\/\/doi.org\/10.1038\/s41598-019-53240-z","journal-title":"Sci Rep"},{"key":"9202_CR43","doi-asserted-by":"publisher","first-page":"925135","DOI":"10.1155\/2012\/925135","volume":"2012","author":"RV Luckheeram","year":"2012","unstructured":"Luckheeram RV, Zhou R, Verma AD, Xia B (2012) CD4+T cells: differentiation and functions. Clin Dev Immunol 2012:925135. https:\/\/doi.org\/10.1155\/2012\/925135","journal-title":"Clin Dev Immunol"},{"key":"9202_CR44","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/jdv.16563","volume":"35","author":"J Chen","year":"2021","unstructured":"Chen J, Li C, Li H et al (2021) Identification of a TH 2-high psoriasis cluster based on skin biomarker analysis in a Chinese psoriasis population. J Eur Acad Dermatol Venereol 35:150\u2013158. https:\/\/doi.org\/10.1111\/jdv.16563","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"9202_CR45","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1097\/CM9.0000000000001228","volume":"133","author":"J Zhu","year":"2020","unstructured":"Zhu J, Shi X-F, Chu C-Q (2020) Autoantibodies in psoriatic arthritis: are they of pathogenic relevance? Chin Med J (Engl) 133:2899\u20132901. https:\/\/doi.org\/10.1097\/CM9.0000000000001228","journal-title":"Chin Med J (Engl)"},{"key":"9202_CR46","doi-asserted-by":"publisher","first-page":"7346030","DOI":"10.1155\/2016\/7346030","volume":"2016","author":"Y Wang","year":"2016","unstructured":"Wang Y, Wang L, Yang H et al (2016) Activated Circulating T Follicular Helper Cells Are Associated with Disease Severity in Patients with Psoriasis. J Immunol Res 2016:7346030. https:\/\/doi.org\/10.1155\/2016\/7346030","journal-title":"J Immunol Res"},{"key":"9202_CR47","doi-asserted-by":"publisher","first-page":"219ra8","DOI":"10.1126\/scitranslmed.3007828","volume":"6","author":"C Schlapbach","year":"2014","unstructured":"Schlapbach C, Gehad A, Yang C et al (2014) Human TH9 cells are skin-tropic and have autocrine and paracrine proinflammatory capacity. Sci Transl Med 6:219ra8. https:\/\/doi.org\/10.1126\/scitranslmed.3007828","journal-title":"Sci Transl Med"},{"key":"9202_CR48","doi-asserted-by":"publisher","first-page":"7692024","DOI":"10.1155\/2016\/7692024","volume":"2016","author":"M Diani","year":"2016","unstructured":"Diani M, Altomare G, Reali E (2016) T Helper Cell Subsets in Clinical Manifestations of Psoriasis. J Immunol Res 2016:7692024. https:\/\/doi.org\/10.1155\/2016\/7692024","journal-title":"J Immunol Res"},{"key":"9202_CR49","doi-asserted-by":"publisher","first-page":"5451","DOI":"10.1007\/s12325-025-03363-9","volume":"42","author":"G Han","year":"2025","unstructured":"Han G, Armstrong A, Krueger JG, Jacobson A (2025) IL-17\u00a0C as a Driver of Inflammation in Psoriasis. Adv Ther 42:5451\u20135467. https:\/\/doi.org\/10.1007\/s12325-025-03363-9","journal-title":"Adv Ther"},{"key":"9202_CR50","doi-asserted-by":"publisher","first-page":"qiae254","DOI":"10.1093\/jleuko\/qiae254","volume":"117","author":"J Saavedra-Almarza","year":"2025","unstructured":"Saavedra-Almarza J, Malgue F, Garc\u00eda-G\u00f3mez M et al (2025) Unveiling the role of resident memory T cells in psoriasis. J Leukoc Biol 117:qiae254. https:\/\/doi.org\/10.1093\/jleuko\/qiae254","journal-title":"J Leukoc Biol"},{"key":"9202_CR51","doi-asserted-by":"publisher","first-page":"e955393","DOI":"10.4161\/21623988.2014.955393","volume":"3","author":"NL Glosson-Byers","year":"2014","unstructured":"Glosson-Byers NL, Sehra S, Kaplan MH (2014) STAT4 is required for IL-23 responsiveness in Th17 memory cells and NKT cells. JAKSTAT 3:e955393. https:\/\/doi.org\/10.4161\/21623988.2014.955393","journal-title":"JAKSTAT"},{"key":"9202_CR52","doi-asserted-by":"publisher","first-page":"4901","DOI":"10.4049\/jimmunol.178.8.4901","volume":"178","author":"AN Mathur","year":"2007","unstructured":"Mathur AN, Chang H-C, Zisoulis DG et al (2007) Stat3 and Stat4 direct development of IL-17-secreting Th cells. J Immunol 178:4901\u20134907. https:\/\/doi.org\/10.4049\/jimmunol.178.8.4901","journal-title":"J Immunol"},{"key":"9202_CR53","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3390\/life12020234","volume":"12","author":"D Antal","year":"2022","unstructured":"Antal D, Alimohammadi S, Bai P et al (2022) Antigen-Presenting Cells in Psoriasis. Life (Basel) 12:234. https:\/\/doi.org\/10.3390\/life12020234","journal-title":"Life (Basel)"},{"key":"9202_CR54","doi-asserted-by":"publisher","first-page":"771","DOI":"10.3390\/ijms25020771","volume":"25","author":"Y Gao","year":"2024","unstructured":"Gao Y, Gong B, Chen Z et al (2024) Damage-Associated Molecular Patterns, a Class of Potential Psoriasis Drug Targets. Int J Mol Sci 25:771. https:\/\/doi.org\/10.3390\/ijms25020771","journal-title":"Int J Mol Sci"},{"key":"9202_CR55","doi-asserted-by":"publisher","first-page":"540","DOI":"10.3390\/ijms23010540","volume":"23","author":"E Kelemen","year":"2022","unstructured":"Kelemen E, \u00c1d\u00e1m \u00c9, S\u00e1gi SM et al (2022) Psoriasis-Associated Inflammatory Conditions Induce IL-23 mRNA Expression in Normal Human Epidermal Keratinocytes. Int J Mol Sci 23:540. https:\/\/doi.org\/10.3390\/ijms23010540","journal-title":"Int J Mol Sci"},{"key":"9202_CR56","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.coisb.2019.10.011","volume":"18","author":"K Sheu","year":"2019","unstructured":"Sheu K, Luecke S, Hoffmann A (2019) Stimulus-specificity in the Responses of Immune Sentinel Cells. Curr Opin Syst Biol 18:53\u201361. https:\/\/doi.org\/10.1016\/j.coisb.2019.10.011","journal-title":"Curr Opin Syst Biol"},{"key":"9202_CR57","doi-asserted-by":"publisher","first-page":"e12945","DOI":"10.1111\/sji.12945","volume":"92","author":"LL Ten Bergen","year":"2020","unstructured":"Ten Bergen LL, Petrovic A, Aarebrot AK, Appel S (2020) Current knowledge on autoantigens and autoantibodies in psoriasis. Scand J Immunol 92:e12945. https:\/\/doi.org\/10.1111\/sji.12945","journal-title":"Scand J Immunol"},{"key":"9202_CR58","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.3390\/molecules27061953","volume":"27","author":"A Alesci","year":"2022","unstructured":"Alesci A, Lauriano ER, Fumia A et al (2022) Relationship between Immune Cells, Depression, Stress, and Psoriasis: Could the Use of Natural Products. Be Helpful? Molecules 27:1953. https:\/\/doi.org\/10.3390\/molecules27061953","journal-title":"Be Helpful? Molecules"},{"key":"9202_CR59","doi-asserted-by":"publisher","first-page":"1546422","DOI":"10.3389\/fimmu.2025.1546422","volume":"16","author":"R Lande","year":"2025","unstructured":"Lande R, Mennella A, Palazzo R et al (2025) The nature of the post-translational modifications of the autoantigen LL37 influences the autoreactive T-helper cell phenotype in psoriasis. Front Immunol 16:1546422. https:\/\/doi.org\/10.3389\/fimmu.2025.1546422","journal-title":"Front Immunol"},{"key":"9202_CR60","doi-asserted-by":"publisher","first-page":"1585378","DOI":"10.3389\/fimmu.2025.1585378","volume":"16","author":"Y Chen","year":"2025","unstructured":"Chen Y, Tontini C, Tosi I et al (2025) Circulating CD8 T cells from patients with mild-to-moderate psoriasis are functionally impaired. Front Immunol 16:1585378. https:\/\/doi.org\/10.3389\/fimmu.2025.1585378","journal-title":"Front Immunol"},{"key":"9202_CR61","doi-asserted-by":"publisher","first-page":"788940","DOI":"10.3389\/fimmu.2021.788940","volume":"12","author":"P Hu","year":"2021","unstructured":"Hu P, Wang M, Gao H et al (2021) The Role of Helper T Cells in Psoriasis. Front Immunol 12:788940. https:\/\/doi.org\/10.3389\/fimmu.2021.788940","journal-title":"Front Immunol"},{"key":"9202_CR62","doi-asserted-by":"publisher","first-page":"2828","DOI":"10.3390\/biomedicines10112828","volume":"10","author":"W Narinyan","year":"2022","unstructured":"Narinyan W, Poladian N, Orujyan D et al (2022) Immunologic Role of Innate Lymphoid Cells against Mycobacterial tuberculosis Infection. Biomedicines 10:2828. https:\/\/doi.org\/10.3390\/biomedicines10112828","journal-title":"Biomedicines"},{"key":"9202_CR63","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1084\/jem.20041964","volume":"201","author":"G Gautier","year":"2005","unstructured":"Gautier G, Humbert M, Deauvieau F et al (2005) A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells. J Exp Med 201:1435\u20131446. https:\/\/doi.org\/10.1084\/jem.20041964","journal-title":"J Exp Med"},{"key":"9202_CR64","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41541-024-00869-1","volume":"9","author":"BC Gilmour","year":"2024","unstructured":"Gilmour BC, Corthay A, \u00d8ynebr\u00e5ten I (2024) High production of IL-12 by human dendritic cells stimulated with combinations of pattern-recognition receptor agonists. NPJ Vaccines 9:83. https:\/\/doi.org\/10.1038\/s41541-024-00869-1","journal-title":"NPJ Vaccines"},{"key":"9202_CR65","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1089\/10799900360708632","volume":"23","author":"L Hibbert","year":"2003","unstructured":"Hibbert L, Pflanz S, De Waal Malefyt R, Kastelein RA (2003) IL-27 and IFN-alpha signal via Stat1 and Stat3 and induce T-Bet and IL-12Rbeta2 in naive T cells. J Interferon Cytokine Res 23:513\u2013522. https:\/\/doi.org\/10.1089\/10799900360708632","journal-title":"J Interferon Cytokine Res"},{"key":"9202_CR66","doi-asserted-by":"publisher","first-page":"168","DOI":"10.7150\/ijbs.10464","volume":"11","author":"AE Abdalla","year":"2015","unstructured":"Abdalla AE, Li Q, Xie L, Xie J (2015) Biology of IL-27 and its role in the host immunity against Mycobacterium tuberculosis. Int J Biol Sci 11:168\u2013175. https:\/\/doi.org\/10.7150\/ijbs.10464","journal-title":"Int J Biol Sci"},{"key":"9202_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5114\/ada.2025.147548","volume":"42","author":"M Majchrzycka","year":"2025","unstructured":"Majchrzycka M, Wegner J, Adamski Z, Jenerowicz D (2025) Interleukins 30 and 27 in psoriasis and inflammation. Postepy Dermatol Alergol 42:1\u20134. https:\/\/doi.org\/10.5114\/ada.2025.147548","journal-title":"Postepy Dermatol Alergol"},{"key":"9202_CR68","doi-asserted-by":"publisher","first-page":"e1008994","DOI":"10.1371\/journal.ppat.1008994","volume":"16","author":"M Montes de Oca","year":"2020","unstructured":"Montes de Oca M, de Labastida Rivera F, Winterford C et al (2020) IL-27 signalling regulates glycolysis in Th1 cells to limit immunopathology during infection. PLoS Pathog 16:e1008994. https:\/\/doi.org\/10.1371\/journal.ppat.1008994","journal-title":"PLoS Pathog"},{"key":"9202_CR69","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1615\/CritRevImmunol.2016017387","volume":"36","author":"AY Mah","year":"2016","unstructured":"Mah AY, Cooper MA (2016) Metabolic Regulation of Natural Killer Cell IFN-\u03b3 Production. Crit Rev Immunol 36:131\u2013147. https:\/\/doi.org\/10.1615\/CritRevImmunol.2016017387","journal-title":"Crit Rev Immunol"},{"key":"9202_CR70","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/ni794","volume":"3","author":"M Afkarian","year":"2002","unstructured":"Afkarian M, Sedy JR, Yang J et al (2002) T-bet is a STAT1-induced regulator of IL-12R expression in na\u00efve CD4\u2009+\u2009T cells. Nat Immunol 3:549\u2013557. https:\/\/doi.org\/10.1038\/ni794","journal-title":"Nat Immunol"},{"key":"9202_CR71","doi-asserted-by":"publisher","first-page":"4684","DOI":"10.4049\/jimmunol.1200606","volume":"189","author":"NR Ford","year":"2012","unstructured":"Ford NR, Miller HE, Reeme AE et al (2012) Inflammatory signals direct expression of human IL12RB1 into multiple distinct isoforms. J Immunol 189:4684\u20134694. https:\/\/doi.org\/10.4049\/jimmunol.1200606","journal-title":"J Immunol"},{"key":"9202_CR72","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/s41577-018-0029-z","volume":"18","author":"LB Ivashkiv","year":"2018","unstructured":"Ivashkiv LB (2018) IFN\u03b3: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy. Nat Rev Immunol 18:545\u2013558. https:\/\/doi.org\/10.1038\/s41577-018-0029-z","journal-title":"Nat Rev Immunol"},{"key":"9202_CR73","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1002\/eji.1830260216","volume":"26","author":"MK Kennedy","year":"1996","unstructured":"Kennedy MK, Picha KS, Fanslow WC et al (1996) CD40\/CD40 ligand interactions are required for T cell-dependent production of interleukin-12 by mouse macrophages. Eur J Immunol 26:370\u2013378. https:\/\/doi.org\/10.1002\/eji.1830260216","journal-title":"Eur J Immunol"},{"key":"9202_CR74","doi-asserted-by":"publisher","first-page":"100263","DOI":"10.1016\/j.jtauto.2024.100263","volume":"10","author":"X Cui","year":"2025","unstructured":"Cui X, Liu W, Jiang H et al (2025) IL-12 family cytokines and autoimmune diseases: A potential therapeutic target? J Transl Autoimmun 10:100263. https:\/\/doi.org\/10.1016\/j.jtauto.2024.100263","journal-title":"J Transl Autoimmun"},{"key":"9202_CR75","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.micinf.2009.04.001","volume":"11","author":"C Dong","year":"2009","unstructured":"Dong C (2009) Differentiation and function of pro-inflammatory Th17 cells. Microbes Infect 11:584\u2013588. https:\/\/doi.org\/10.1016\/j.micinf.2009.04.001","journal-title":"Microbes Infect"},{"key":"9202_CR76","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/nature05969","volume":"448","author":"R Nurieva","year":"2007","unstructured":"Nurieva R, Yang XO, Martinez G et al (2007) Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 448:480\u2013483. https:\/\/doi.org\/10.1038\/nature05969","journal-title":"Nature"},{"key":"9202_CR77","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1084\/jem.20041257","volume":"201","author":"CL Langrish","year":"2005","unstructured":"Langrish CL, Chen Y, Blumenschein WM et al (2005) IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 201:233\u2013240. https:\/\/doi.org\/10.1084\/jem.20041257","journal-title":"J Exp Med"},{"key":"9202_CR78","doi-asserted-by":"publisher","first-page":"e91663","DOI":"10.1172\/jci.insight.91663","volume":"2","author":"PW Lee","year":"2017","unstructured":"Lee PW, Smith AJ, Yang Y et al (2017) IL-23R-activated STAT3\/STAT4 is essential for Th1\/Th17-mediated CNS autoimmunity. JCI Insight 2:e91663. https:\/\/doi.org\/10.1172\/jci.insight.91663","journal-title":"JCI Insight"},{"key":"9202_CR79","doi-asserted-by":"publisher","first-page":"140","DOI":"10.33696\/immunology.4.140","volume":"4","author":"JC Kleiner","year":"2022","unstructured":"Kleiner JC, Krebs CF (2022) Persistence, Pathogenicity and Plasticity: The Role of IL-23 in Th17 Fate. J Cell Immunol 4:140. https:\/\/doi.org\/10.33696\/immunology.4.140","journal-title":"J Cell Immunol"},{"key":"9202_CR80","doi-asserted-by":"publisher","first-page":"5699","DOI":"10.4049\/jimmunol.168.11.5699","volume":"168","author":"C Parham","year":"2002","unstructured":"Parham C, Chirica M, Timans J et al (2002) A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R. J Immunol 168:5699\u20135708. https:\/\/doi.org\/10.4049\/jimmunol.168.11.5699","journal-title":"J Immunol"},{"key":"9202_CR81","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.cyto.2014.11.018","volume":"71","author":"RT Robinson","year":"2015","unstructured":"Robinson RT (2015) IL12R\u03b21: the cytokine receptor that we used to know. Cytokine 71:348\u2013359. https:\/\/doi.org\/10.1016\/j.cyto.2014.11.018","journal-title":"Cytokine"},{"key":"9202_CR82","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.3390\/ijms21041275","volume":"21","author":"M Furue","year":"2020","unstructured":"Furue M, Furue K, Tsuji G, Nakahara T (2020) Interleukin-17A and Keratinocytes in Psoriasis. Int J Mol Sci 21:1275. https:\/\/doi.org\/10.3390\/ijms21041275","journal-title":"Int J Mol Sci"},{"key":"9202_CR83","doi-asserted-by":"publisher","first-page":"5621","DOI":"10.1038\/ncomms6621","volume":"5","author":"R Lande","year":"2014","unstructured":"Lande R, Botti E, Jandus C et al (2014) The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis. Nat Commun 5:5621. https:\/\/doi.org\/10.1038\/ncomms6621","journal-title":"Nat Commun"},{"key":"9202_CR84","doi-asserted-by":"publisher","first-page":"1081256","DOI":"10.3389\/fimmu.2023.1081256","volume":"14","author":"P Zhang","year":"2023","unstructured":"Zhang P, Su Y, Li S et al (2023) The roles of T cells in psoriasis. Front Immunol 14:1081256. https:\/\/doi.org\/10.3389\/fimmu.2023.1081256","journal-title":"Front Immunol"},{"key":"9202_CR85","doi-asserted-by":"publisher","first-page":"a028480","DOI":"10.1101\/cshperspect.a028480","volume":"11","author":"E Alspach","year":"2019","unstructured":"Alspach E, Lussier DM, Schreiber RD (2019) Interferon \u03b3 and Its Important Roles in Promoting and Inhibiting Spontaneous and Therapeutic Cancer Immunity. Cold Spring Harb Perspect Biol 11:a028480. https:\/\/doi.org\/10.1101\/cshperspect.a028480","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"9202_CR86","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1089\/jir.2007.0145","volume":"28","author":"JM Reed","year":"2008","unstructured":"Reed JM, Branigan PJ, Bamezai A (2008) Interferon gamma enhances clonal expansion and survival of CD4\u2009+\u2009T cells. J Interferon Cytokine Res 28:611\u2013622. https:\/\/doi.org\/10.1089\/jir.2007.0145","journal-title":"J Interferon Cytokine Res"},{"key":"9202_CR87","doi-asserted-by":"publisher","first-page":"831084","DOI":"10.3389\/fopht.2022.831084","volume":"2","author":"H Shao","year":"2022","unstructured":"Shao H, Kaplan HJ, Sun D (2022) Bidirectional Effect of IFN-\u03b3 on Th17 Responses in Experimental Autoimmune Uveitis. Front Ophthalmol (Lausanne) 2:831084. https:\/\/doi.org\/10.3389\/fopht.2022.831084","journal-title":"Front Ophthalmol (Lausanne)"},{"key":"9202_CR88","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.immuni.2015.02.003","volume":"42","author":"CC Brown","year":"2015","unstructured":"Brown CC, Esterhazy D, Sarde A et al (2015) Retinoic acid is essential for Th1 cell lineage stability and prevents transition to a Th17 cell program. Immunity 42:499\u2013511. https:\/\/doi.org\/10.1016\/j.immuni.2015.02.003","journal-title":"Immunity"},{"key":"9202_CR89","doi-asserted-by":"publisher","first-page":"e194631","DOI":"10.1172\/JCI194631","volume":"136","author":"P Goala","year":"2026","unstructured":"Goala P, Zhang Y, Beatty N et al (2026) IFN-\u03b3-driven skewing towards Th1 over Th17 differentiation underlies CRS and neutropenia in CAR-T therapy. J Clin Invest 136:e194631. https:\/\/doi.org\/10.1172\/JCI194631","journal-title":"J Clin Invest"},{"key":"9202_CR90","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nature22360","volume":"546","author":"AG Levine","year":"2017","unstructured":"Levine AG, Mendoza A, Hemmers S et al (2017) Stability and function of regulatory T cells expressing the transcription factor T-bet. Nature 546:421\u2013425. https:\/\/doi.org\/10.1038\/nature22360","journal-title":"Nature"},{"key":"9202_CR91","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/s41423-022-00869-y","volume":"19","author":"G Thangavelu","year":"2022","unstructured":"Thangavelu G, Andrejeva G, Bolivar-Wagers S et al (2022) Retinoic acid signaling acts as a rheostat to balance Treg function. Cell Mol Immunol 19:820\u2013833. https:\/\/doi.org\/10.1038\/s41423-022-00869-y","journal-title":"Cell Mol Immunol"},{"key":"9202_CR92","doi-asserted-by":"publisher","first-page":"e012165","DOI":"10.1136\/jitc-2025-012165","volume":"13","author":"AM Krieg","year":"2025","unstructured":"Krieg AM (2025) New insights into the role of IFN-\u03b1\/\u03b2 and TLR7\/8\/9 in cancer immunotherapy and systemic autoimmunity. J Immunother Cancer 13:e012165. https:\/\/doi.org\/10.1136\/jitc-2025-012165","journal-title":"J Immunother Cancer"},{"key":"9202_CR93","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1084\/jem.20050500","volume":"202","author":"FO Nestle","year":"2005","unstructured":"Nestle FO, Conrad C, Tun-Kyi A et al (2005) Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production. J Exp Med 202:135\u2013143. https:\/\/doi.org\/10.1084\/jem.20050500","journal-title":"J Exp Med"},{"key":"9202_CR94","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.bbrc.2008.05.081","volume":"372","author":"S Zhang","year":"2008","unstructured":"Zhang S, Wang Q (2008) Factors determining the formation and release of bioactive IL-12: regulatory mechanisms for IL-12p70 synthesis and inhibition. Biochem Biophys Res Commun 372:509\u2013512. https:\/\/doi.org\/10.1016\/j.bbrc.2008.05.081","journal-title":"Biochem Biophys Res Commun"},{"key":"9202_CR95","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1016\/j.molimm.2011.07.008","volume":"48","author":"ML Hansen","year":"2011","unstructured":"Hansen ML, Woetmann A, Krejsgaard T et al (2011) IFN-\u03b1 primes T- and NK-cells for IL-15-mediated signaling and cytotoxicity. Mol Immunol 48:2087\u20132093. https:\/\/doi.org\/10.1016\/j.molimm.2011.07.008","journal-title":"Mol Immunol"},{"key":"9202_CR96","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1002\/eji.200839010","volume":"39","author":"SK Watkins","year":"2009","unstructured":"Watkins SK, Li B, Richardson KS et al (2009) Rapid release of cytoplasmic IL-15 from tumor-associated macrophages is an initial and critical event in IL-12-initiated tumor regression. Eur J Immunol 39:2126\u20132135. https:\/\/doi.org\/10.1002\/eji.200839010","journal-title":"Eur J Immunol"},{"key":"9202_CR97","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/j.1365-2567.2008.02878.x","volume":"126","author":"R R\u00fcckert","year":"2009","unstructured":"R\u00fcckert R, Brandt K, Ernst M et al (2009) Interleukin-15 stimulates macrophages to activate CD4\u2009+\u2009T cells: a role in the pathogenesis of rheumatoid arthritis? Immunology 126:63\u201373. https:\/\/doi.org\/10.1111\/j.1365-2567.2008.02878.x","journal-title":"Immunology"},{"key":"9202_CR98","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/1479-5876-7-109","volume":"7","author":"S Anguille","year":"2009","unstructured":"Anguille S, Smits ELJM, Cools N et al (2009) Short-term cultured, interleukin-15 differentiated dendritic cells have potent immunostimulatory properties. J Transl Med 7:109. https:\/\/doi.org\/10.1186\/1479-5876-7-109","journal-title":"J Transl Med"},{"key":"9202_CR99","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1182\/blood-2009-08-236521","volume":"115","author":"W-W Lee","year":"2010","unstructured":"Lee W-W, Kang SW, Choi J et al (2010) Regulating human Th17 cells via differential expression of IL-1 receptor. Blood 115:530\u2013540. https:\/\/doi.org\/10.1182\/blood-2009-08-236521","journal-title":"Blood"},{"key":"9202_CR100","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.3389\/fimmu.2018.01986","volume":"9","author":"H Nagashima","year":"2018","unstructured":"Nagashima H, Ishii N, So T (2018) Regulation of Interleukin-6 Receptor Signaling by TNF Receptor-Associated Factor 2 and 5 During Differentiation of Inflammatory CD4\u2009+\u2009T Cells. Front Immunol 9:1986. https:\/\/doi.org\/10.3389\/fimmu.2018.01986","journal-title":"Front Immunol"},{"key":"9202_CR101","doi-asserted-by":"publisher","first-page":"e70211","DOI":"10.1002\/iid3.70211","volume":"13","author":"AHH Alshihmani","year":"2025","unstructured":"Alshihmani AHH, Mahmoudi M, Kheder RK et al (2025) The M2 Macrophages Importance Role in Psoriasis. Immun Inflamm Dis 13:e70211. https:\/\/doi.org\/10.1002\/iid3.70211","journal-title":"Immun Inflamm Dis"},{"key":"9202_CR102","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/imm.12938","volume":"155","author":"S Zhang","year":"2018","unstructured":"Zhang S (2018) The role of transforming growth factor \u03b2 in T helper 17 differentiation. Immunology 155:24\u201335. https:\/\/doi.org\/10.1111\/imm.12938","journal-title":"Immunology"},{"key":"9202_CR103","doi-asserted-by":"publisher","first-page":"875","DOI":"10.3390\/ijms24010875","volume":"24","author":"R Amagai","year":"2023","unstructured":"Amagai R, Takahashi T, Terui H et al (2023) The Antimicrobial Peptide Cathelicidin Exerts Immunomodulatory Effects via Scavenger Receptors. Int J Mol Sci 24:875. https:\/\/doi.org\/10.3390\/ijms24010875","journal-title":"Int J Mol Sci"},{"key":"9202_CR104","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.4049\/jimmunol.1402388","volume":"194","author":"Y Nakagawa","year":"2015","unstructured":"Nakagawa Y, Gallo RL (2015) Endogenous intracellular cathelicidin enhances TLR9 activation in dendritic cells and macrophages. J Immunol 194:1274\u20131284. https:\/\/doi.org\/10.4049\/jimmunol.1402388","journal-title":"J Immunol"},{"key":"9202_CR105","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.imbio.2008.12.003","volume":"214","author":"J Hurst","year":"2009","unstructured":"Hurst J, Prinz N, Lorenz M et al (2009) TLR7 and TLR8 ligands and antiphospholipid antibodies show synergistic effects on the induction of IL-1beta and caspase-1 in monocytes and dendritic cells. Immunobiology 214:683\u2013691. https:\/\/doi.org\/10.1016\/j.imbio.2008.12.003","journal-title":"Immunobiology"},{"key":"9202_CR106","doi-asserted-by":"publisher","first-page":"1092799","DOI":"10.3389\/fimmu.2023.1092799","volume":"14","author":"S Unterberger","year":"2023","unstructured":"Unterberger S, Mullen L, Flint MS, Sacre S (2023) Multiple TLRs elicit alternative NLRP3 inflammasome activation in primary human monocytes independent of RIPK1 kinase activity. Front Immunol 14:1092799. https:\/\/doi.org\/10.3389\/fimmu.2023.1092799","journal-title":"Front Immunol"},{"key":"9202_CR107","doi-asserted-by":"publisher","first-page":"12202","DOI":"10.1038\/s41598-026-46534-6","volume":"16","author":"S Dreschers","year":"2026","unstructured":"Dreschers S, Heiler E, Oppermann L et al (2026) TLR7\/8 signaling balances cytokine responses in neonatal monocytes. Sci Rep 16:12202. https:\/\/doi.org\/10.1038\/s41598-026-46534-6","journal-title":"Sci Rep"},{"key":"9202_CR108","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1002\/eji.200737602","volume":"38","author":"TJ Vanden Bush","year":"2008","unstructured":"Vanden Bush TJ, Bishop GA (2008) TLR7 and CD40 cooperate in IL-6 production via enhanced JNK and AP-1 activation. Eur J Immunol 38:400\u2013409. https:\/\/doi.org\/10.1002\/eji.200737602","journal-title":"Eur J Immunol"},{"key":"9202_CR109","doi-asserted-by":"publisher","first-page":"93","DOI":"10.4049\/immunohorizons.2000002","volume":"4","author":"AT Bender","year":"2020","unstructured":"Bender AT, Tzvetkov E, Pereira A et al (2020) TLR7 and TLR8 Differentially Activate the IRF and NF-\u03baB Pathways in Specific Cell Types to Promote Inflammation. Immunohorizons 4:93\u2013107. https:\/\/doi.org\/10.4049\/immunohorizons.2000002","journal-title":"Immunohorizons"},{"key":"9202_CR110","doi-asserted-by":"publisher","first-page":"3582","DOI":"10.3390\/cancers17213582","volume":"17","author":"J Mondal","year":"2025","unstructured":"Mondal J, Prabha S, Griffith TS et al (2025) Enhancing Cancer Therapy with TLR7\/8 Agonists: Applications in Vaccines and Combination Treatments. Cancers (Basel) 17:3582. https:\/\/doi.org\/10.3390\/cancers17213582","journal-title":"Cancers (Basel)"},{"key":"9202_CR111","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/j.1600-065X.2011.01004.x","volume":"241","author":"G Cheng","year":"2011","unstructured":"Cheng G, Yu A, Malek TR (2011) T-cell tolerance and the multi-functional role of IL-2R signaling in T-regulatory cells. Immunol Rev 241:63\u201376. https:\/\/doi.org\/10.1111\/j.1600-065X.2011.01004.x","journal-title":"Immunol Rev"},{"key":"9202_CR112","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/ar1905","volume":"8","author":"F Dodeller","year":"2006","unstructured":"Dodeller F, Schulze-Koops H (2006) The p38 mitogen-activated protein kinase signaling cascade in CD4 T cells. Arthritis Res Ther 8:205. https:\/\/doi.org\/10.1186\/ar1905","journal-title":"Arthritis Res Ther"},{"key":"9202_CR113","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1073\/pnas.1713301115","volume":"115","author":"ML Giardino Torchia","year":"2018","unstructured":"Giardino Torchia ML, Dutta D, Mittelstadt PR et al (2018) Intensity and duration of TCR signaling is limited by p38 phosphorylation of ZAP-70T293 and destabilization of the signalosome. Proc Natl Acad Sci U S A 115:2174\u20132179. https:\/\/doi.org\/10.1073\/pnas.1713301115","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9202_CR114","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1084\/jem.20131917","volume":"211","author":"MS Alam","year":"2014","unstructured":"Alam MS, Gaida MM, Ogawa Y et al (2014) Counter-regulation of T cell effector function by differentially activated p38. J Exp Med 211:1257\u20131270. https:\/\/doi.org\/10.1084\/jem.20131917","journal-title":"J Exp Med"},{"key":"9202_CR115","doi-asserted-by":"publisher","first-page":"e2004111","DOI":"10.1371\/journal.pbio.2004111","volume":"16","author":"MS Alam","year":"2018","unstructured":"Alam MS, Gaida MM, Debnath S et al (2018) Unique properties of TCR-activated p38 are necessary for NFAT-dependent T-cell activation. PLoS Biol 16:e2004111. https:\/\/doi.org\/10.1371\/journal.pbio.2004111","journal-title":"PLoS Biol"},{"key":"9202_CR116","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1038\/ni.2710","volume":"14","author":"K Man","year":"2013","unstructured":"Man K, Miasari M, Shi W et al (2013) The transcription factor IRF4 is essential for TCR affinity-mediated metabolic programming and clonal expansion of T cells. Nat Immunol 14:1155\u20131165. https:\/\/doi.org\/10.1038\/ni.2710","journal-title":"Nat Immunol"},{"key":"9202_CR117","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.1182\/blood-2009-10-233585","volume":"115","author":"N Hermann-Kleiter","year":"2010","unstructured":"Hermann-Kleiter N, Baier G (2010) NFAT pulls the strings during CD4\u2009+\u2009T helper cell effector functions. Blood 115:2989\u20132997. https:\/\/doi.org\/10.1182\/blood-2009-10-233585","journal-title":"Blood"},{"key":"9202_CR118","doi-asserted-by":"publisher","first-page":"4698","DOI":"10.1038\/s41467-019-12680-x","volume":"10","author":"H Yahia-Cherbal","year":"2019","unstructured":"Yahia-Cherbal H, Rybczynska M, Lovecchio D et al (2019) NFAT primes the human RORC locus for ROR\u03b3t expression in CD4\u2009+\u2009T cells. Nat Commun 10:4698. https:\/\/doi.org\/10.1038\/s41467-019-12680-x","journal-title":"Nat Commun"},{"key":"9202_CR119","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.immuni.2009.12.003","volume":"32","author":"MF Gulen","year":"2010","unstructured":"Gulen MF, Kang Z, Bulek K et al (2010) The receptor SIGIRR suppresses Th17 cell proliferation via inhibition of the interleukin-1 receptor pathway and mTOR kinase activation. Immunity 32:54\u201366. https:\/\/doi.org\/10.1016\/j.immuni.2009.12.003","journal-title":"Immunity"},{"key":"9202_CR120","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.immuni.2009.02.007","volume":"30","author":"Y Chung","year":"2009","unstructured":"Chung Y, Chang SH, Martinez GJ et al (2009) Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. Immunity 30:576\u2013587. https:\/\/doi.org\/10.1016\/j.immuni.2009.02.007","journal-title":"Immunity"},{"key":"9202_CR121","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3389\/fimmu.2016.00543","volume":"7","author":"Y Sha","year":"2016","unstructured":"Sha Y, Markovic-Plese S (2016) Activated IL-1RI Signaling Pathway Induces Th17 Cell Differentiation via Interferon Regulatory Factor 4 Signaling in Patients with Relapsing-Remitting Multiple Sclerosis. Front Immunol 7:543. https:\/\/doi.org\/10.3389\/fimmu.2016.00543","journal-title":"Front Immunol"},{"key":"9202_CR122","doi-asserted-by":"publisher","unstructured":"Pastor-Fern\u00e1ndez G, Mariblanca IR, Navarro MN (2020) Decoding IL-23 Signaling Cascade for New Therapeutic Opportunities. https:\/\/doi.org\/10.3390\/cells9092044. Cells 9:2044","DOI":"10.3390\/cells9092044"},{"key":"9202_CR123","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1186\/s12974-025-03591-4","volume":"22","author":"DS Prado","year":"2025","unstructured":"Prado DS, Kutuva AR, Cattley RT et al (2025) STAT3 S727 phosphorylation drives pathogenic Th17 differentiation and neuroinflammation in autoimmune disease. J Neuroinflammation 22:246. https:\/\/doi.org\/10.1186\/s12974-025-03591-4","journal-title":"J Neuroinflammation"},{"key":"9202_CR124","doi-asserted-by":"publisher","first-page":"42534","DOI":"10.1074\/jbc.M106044200","volume":"276","author":"Y Zhang","year":"2001","unstructured":"Zhang Y, Liu G, Dong Z (2001) MSK1 and JNKs mediate phosphorylation of STAT3 in UVA-irradiated mouse epidermal JB6 cells. J Biol Chem 276:42534\u201342542. https:\/\/doi.org\/10.1074\/jbc.M106044200","journal-title":"J Biol Chem"},{"key":"9202_CR125","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41389-020-0195-2","volume":"9","author":"H Qi","year":"2020","unstructured":"Qi H, Yang Z, Dai C et al (2020) STAT3 activates MSK1-mediated histone H3 phosphorylation to promote NFAT signaling in gastric carcinogenesis. Oncogenesis 9:15. https:\/\/doi.org\/10.1038\/s41389-020-0195-2","journal-title":"Oncogenesis"},{"key":"9202_CR126","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.2337\/db14-0273","volume":"63","author":"NH Knudsen","year":"2014","unstructured":"Knudsen NH, Lee C-H (2014) IL-21 and IRF4: A complex partnership in immune and metabolic regulation. Diabetes 63:1838\u20131840. https:\/\/doi.org\/10.2337\/db14-0273","journal-title":"Diabetes"},{"key":"9202_CR127","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1038\/srep01754","volume":"3","author":"S Koch","year":"2013","unstructured":"Koch S, Mousset S, Graser A et al (2013) IL-6 activated integrated BATF\/IRF4 functions in lymphocytes are T-bet-independent and reversed by subcutaneous immunotherapy. Sci Rep 3:1754. https:\/\/doi.org\/10.1038\/srep01754","journal-title":"Sci Rep"},{"key":"9202_CR128","doi-asserted-by":"publisher","unstructured":"Leonard WJ, Wan C-K (2016) IL-21 Signaling in Immunity. F1000Res 5:F1000. https:\/\/doi.org\/10.12688\/f1000research.7634.1. Faculty Rev-224","DOI":"10.12688\/f1000research.7634.1"},{"key":"9202_CR129","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nature11530","volume":"490","author":"P Li","year":"2012","unstructured":"Li P, Spolski R, Liao W et al (2012) BATF-JUN is critical for IRF4-mediated transcription in T cells. Nature 490:543\u2013546. https:\/\/doi.org\/10.1038\/nature11530","journal-title":"Nature"},{"key":"9202_CR130","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1093\/ecco-jcc\/jjy051","volume":"12","author":"G Nizzoli","year":"2018","unstructured":"Nizzoli G, Burrello C, Cribi\u00f9 FM et al (2018) Pathogenicity of In Vivo Generated Intestinal Th17 Lymphocytes is IFN\u03b3 Dependent. J Crohns Colitis 12:981\u2013992. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjy051","journal-title":"J Crohns Colitis"},{"key":"9202_CR131","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1016\/j.jaci.2025.02.008","volume":"155","author":"J Kim","year":"2025","unstructured":"Kim J, Lee J, Lee J et al (2025) Psoriasis harbors multiple pathogenic type 17 T-cell subsets: Selective modulation by risankizumab. J Allergy Clin Immunol 155:1898\u20131912. https:\/\/doi.org\/10.1016\/j.jaci.2025.02.008","journal-title":"J Allergy Clin Immunol"},{"key":"9202_CR132","doi-asserted-by":"publisher","first-page":"4478","DOI":"10.4049\/jimmunol.1203172","volume":"190","author":"R Duhen","year":"2013","unstructured":"Duhen R, Glatigny S, Arbelaez CA et al (2013) Cutting edge: the pathogenicity of IFN-\u03b3-producing Th17 cells is independent of T-bet. J Immunol 190:4478\u20134482. https:\/\/doi.org\/10.4049\/jimmunol.1203172","journal-title":"J Immunol"},{"issue":"9","key":"9202_CR133","first-page":"1","volume":"77","author":"B van Heeswijk","year":"2025","unstructured":"van Heeswijk B, Razawy W, Mus-Otten A et al (2025) IL-23 upregulates IFN-\u03b3 secretion in Th17.1, but not in Th17 or classical Th1 cells. Arthritis Rheumatol 77(9):1","journal-title":"Arthritis Rheumatol"},{"key":"9202_CR134","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1038\/jid.2011.139","volume":"131","author":"HJ Bovenschen","year":"2011","unstructured":"Bovenschen HJ, van de Kerkhof PC, van Erp PE et al (2011) Foxp3\u2009+\u2009regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin. J Invest Dermatol 131:1853\u20131860. https:\/\/doi.org\/10.1038\/jid.2011.139","journal-title":"J Invest Dermatol"},{"key":"9202_CR135","doi-asserted-by":"publisher","first-page":"4348","DOI":"10.3390\/ijms24054348","volume":"24","author":"I Pietraforte","year":"2023","unstructured":"Pietraforte I, Frasca L (2023) Autoreactive T-Cells in Psoriasis: Are They Spoiled Tregs and Can Therapies Restore Their Functions? Int J Mol Sci 24:4348. https:\/\/doi.org\/10.3390\/ijms24054348","journal-title":"Int J Mol Sci"},{"key":"9202_CR136","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1038\/ncomms3209","volume":"4","author":"B Martin","year":"2013","unstructured":"Martin B, Auffray C, Delpoux A et al (2013) Highly self-reactive naive CD4 T cells are prone to differentiate into regulatory T cells. Nat Commun 4:2209. https:\/\/doi.org\/10.1038\/ncomms3209","journal-title":"Nat Commun"},{"key":"9202_CR137","doi-asserted-by":"publisher","first-page":"6857","DOI":"10.4049\/jimmunol.1001601","volume":"185","author":"TA Stoklasek","year":"2010","unstructured":"Stoklasek TA, Colpitts SL, Smilowitz HM, Lefran\u00e7ois L (2010) MHC class I and TCR avidity control the CD8 T cell response to IL-15\/IL-15R\u03b1 complex. J Immunol 185:6857\u20136865. https:\/\/doi.org\/10.4049\/jimmunol.1001601","journal-title":"J Immunol"},{"key":"9202_CR138","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1189\/jlb.2MR0915-441R","volume":"99","author":"N Karin","year":"2016","unstructured":"Karin N, Wildbaum G, Thelen M (2016) Biased signaling pathways via CXCR3 control the development and function of CD4\u2009+\u2009T cell subsets. J Leukoc Biol 99:857\u2013862. https:\/\/doi.org\/10.1189\/jlb.2MR0915-441R","journal-title":"J Leukoc Biol"},{"key":"9202_CR139","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1084\/jem.20080730","volume":"205","author":"M Meiron","year":"2008","unstructured":"Meiron M, Zohar Y, Anunu R et al (2008) CXCL12 (SDF-1alpha) suppresses ongoing experimental autoimmune encephalomyelitis by selecting antigen-specific regulatory T cells. J Exp Med 205:2643\u20132655. https:\/\/doi.org\/10.1084\/jem.20080730","journal-title":"J Exp Med"},{"key":"9202_CR140","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1172\/JCI71951","volume":"124","author":"Y Zohar","year":"2014","unstructured":"Zohar Y, Wildbaum G, Novak R et al (2014) CXCL11-dependent induction of FOXP3-negative regulatory T cells suppresses autoimmune encephalomyelitis. J Clin Invest 124:2009\u20132022. https:\/\/doi.org\/10.1172\/JCI71951","journal-title":"J Clin Invest"},{"key":"9202_CR141","doi-asserted-by":"publisher","first-page":"e70066","DOI":"10.1111\/sji.70066","volume":"102","author":"H Sigurgr\u00edmsd\u00f3ttir","year":"2025","unstructured":"Sigurgr\u00edmsd\u00f3ttir H, Eysteinsd\u00f3ttir JH, Kristj\u00e1nsson \u00c1K et al (2025) Skin-Homing Potential of Peripheral Immune Cells From Psoriasis Patients and the Effects of LL-37 on Their Secretion of Chemokines During Psoriasis-Mimicking Stimulation. Scand J Immunol 102:e70066. https:\/\/doi.org\/10.1111\/sji.70066","journal-title":"Scand J Immunol"},{"key":"9202_CR142","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1111\/j.1365-2230.2004.01638.x","volume":"29","author":"Y Teraki","year":"2004","unstructured":"Teraki Y, Miyake A, Takebayashi R, Shiohara T (2004) Homing receptor and chemokine receptor on intraepidermal T cells in psoriasis vulgaris. Clin Exp Dermatol 29:658\u2013663. https:\/\/doi.org\/10.1111\/j.1365-2230.2004.01638.x","journal-title":"Clin Exp Dermatol"},{"key":"9202_CR143","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s00403-009-0966-2","volume":"302","author":"S-C Chen","year":"2010","unstructured":"Chen S-C, de Groot M, Kinsley D et al (2010) Expression of chemokine receptor CXCR3 by lymphocytes and plasmacytoid dendritic cells in human psoriatic lesions. Arch Dermatol Res 302:113\u2013123. https:\/\/doi.org\/10.1007\/s00403-009-0966-2","journal-title":"Arch Dermatol Res"},{"key":"9202_CR144","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.clim.2017.04.001","volume":"180","author":"M Diani","year":"2017","unstructured":"Diani M, Galasso M, Cozzi C et al (2017) Blood to skin recirculation of CD4\u2009+\u2009memory T cells associates with cutaneous and systemic manifestations of psoriatic disease. Clin Immunol 180:84\u201394. https:\/\/doi.org\/10.1016\/j.clim.2017.04.001","journal-title":"Clin Immunol"},{"key":"9202_CR145","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/jid.2010.280","volume":"131","author":"M Su\u00e1rez-Fari\u00f1as","year":"2011","unstructured":"Su\u00e1rez-Fari\u00f1as M, Fuentes-Duculan J, Lowes MA, Krueger JG (2011) Resolved psoriasis lesions retain expression of a subset of disease-related genes. J Invest Dermatol 131:391\u2013400. https:\/\/doi.org\/10.1038\/jid.2010.280","journal-title":"J Invest Dermatol"},{"key":"9202_CR146","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s00109-015-1367-y","volume":"94","author":"E Witte","year":"2016","unstructured":"Witte E, Kokolakis G, Witte K et al (2016) Interleukin-29 induces epithelial production of CXCR3A ligands and T-cell infiltration. J Mol Med (Berl) 94:391\u2013400. https:\/\/doi.org\/10.1007\/s00109-015-1367-y","journal-title":"J Mol Med (Berl)"},{"key":"9202_CR147","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1152\/physiolgenomics.00157.2002","volume":"13","author":"X Zhou","year":"2003","unstructured":"Zhou X, Krueger JG, Kao M-CJ et al (2003) Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63,100-element oligonucleotide array. Physiol Genomics 13:69\u201378. https:\/\/doi.org\/10.1152\/physiolgenomics.00157.2002","journal-title":"Physiol Genomics"},{"key":"9202_CR148","doi-asserted-by":"publisher","first-page":"9358","DOI":"10.1074\/jbc.C600321200","volume":"282","author":"XO Yang","year":"2007","unstructured":"Yang XO, Panopoulos AD, Nurieva R et al (2007) STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J Biol Chem 282:9358\u20139363. https:\/\/doi.org\/10.1074\/jbc.C600321200","journal-title":"J Biol Chem"},{"key":"9202_CR149","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/ng.3040","volume":"46","author":"SE Flanagan","year":"2014","unstructured":"Flanagan SE, Haapaniemi E, Russell MA et al (2014) Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease. Nat Genet 46:812\u2013814. https:\/\/doi.org\/10.1038\/ng.3040","journal-title":"Nat Genet"},{"key":"9202_CR150","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3390\/ijms19010171","volume":"19","author":"E Calautti","year":"2018","unstructured":"Calautti E, Avalle L, Poli V (2018) Psoriasis: A STAT3-Centric View. Int J Mol Sci 19:171. https:\/\/doi.org\/10.3390\/ijms19010171","journal-title":"Int J Mol Sci"},{"key":"9202_CR151","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1002\/art.40445","volume":"70","author":"JD Mountz","year":"2018","unstructured":"Mountz JD (2018) Editorial: STATus of STAT3 in Psoriatic Arthritis. Arthritis Rheumatol 70:801\u2013804. https:\/\/doi.org\/10.1002\/art.40445","journal-title":"Arthritis Rheumatol"},{"key":"9202_CR152","doi-asserted-by":"publisher","first-page":"758418","DOI":"10.3389\/fimmu.2021.758418","volume":"12","author":"C Macaubas","year":"2021","unstructured":"Macaubas C, Rahman SS, Lavi I et al (2021) High Dimensional Analyses of Circulating Immune Cells in Psoriatic Arthritis Detects Elevated Phosphorylated STAT3. Front Immunol 12:758418. https:\/\/doi.org\/10.3389\/fimmu.2021.758418","journal-title":"Front Immunol"},{"key":"9202_CR153","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1111\/jdv.13027","volume":"29","author":"J Niu","year":"2015","unstructured":"Niu J, Song Z, Yang X et al (2015) Increased circulating follicular helper T cells and activated B cells correlate with disease severity in patients with psoriasis. J Eur Acad Dermatol Venereol 29:1791\u20131796. https:\/\/doi.org\/10.1111\/jdv.13027","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"9202_CR154","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.imlet.2016.09.008","volume":"181","author":"Y Wang","year":"2017","unstructured":"Wang Y, Wang L, Shi Y et al (2017) Altered circulating T follicular helper cell subsets in patients with psoriasis vulgaris. Immunol Lett 181:101\u2013108. https:\/\/doi.org\/10.1016\/j.imlet.2016.09.008","journal-title":"Immunol Lett"},{"key":"9202_CR155","doi-asserted-by":"publisher","first-page":"3529","DOI":"10.1038\/s41598-018-21389-8","volume":"8","author":"J Alshekaili","year":"2018","unstructured":"Alshekaili J, Chand R, Lee CE et al (2018) STAT3 regulates cytotoxicity of human CD57\u2009+\u2009CD4+ T cells in blood and lymphoid follicles. Sci Rep 8:3529. https:\/\/doi.org\/10.1038\/s41598-018-21389-8","journal-title":"Sci Rep"},{"key":"9202_CR156","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jdermsci.2015.11.007","volume":"81","author":"L Yang","year":"2016","unstructured":"Yang L, Li B, Dang E et al (2016) Impaired function of regulatory T cells in patients with psoriasis is mediated by phosphorylation of STAT3. J Dermatol Sci 81:85\u201392. https:\/\/doi.org\/10.1016\/j.jdermsci.2015.11.007","journal-title":"J Dermatol Sci"},{"key":"9202_CR157","doi-asserted-by":"publisher","first-page":"770077","DOI":"10.3389\/fped.2022.770077","volume":"10","author":"TP Vogel","year":"2022","unstructured":"Vogel TP, Leiding JW, Cooper MA, Forbes Satter LR (2022) STAT3 gain-of-function syndrome. Front Pediatr 10:770077. https:\/\/doi.org\/10.3389\/fped.2022.770077","journal-title":"Front Pediatr"},{"key":"9202_CR158","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.4049\/jimmunol.1601624","volume":"198","author":"BJ Ulrich","year":"2017","unstructured":"Ulrich BJ, Verdan FF, McKenzie ANJ et al (2017) STAT3 Activation Impairs the Stability of Th9 Cells. J Immunol 198:2302\u20132309. https:\/\/doi.org\/10.4049\/jimmunol.1601624","journal-title":"J Immunol"},{"key":"9202_CR159","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1016\/j.jaci.2018.06.036","volume":"143","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Siegel AM, Sun G et al (2019) Human TH9 differentiation is dependent on signal transducer and activator of transcription (STAT) 3 to restrain STAT1-mediated inhibition. J Allergy Clin Immunol 143:1108\u20131118e4. https:\/\/doi.org\/10.1016\/j.jaci.2018.06.036","journal-title":"J Allergy Clin Immunol"},{"key":"9202_CR160","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/s1074-7613(03)00232-2","volume":"19","author":"F Cheng","year":"2003","unstructured":"Cheng F, Wang H-W, Cuenca A et al (2003) A critical role for Stat3 signaling in immune tolerance. Immunity 19:425\u2013436. https:\/\/doi.org\/10.1016\/s1074-7613(03)00232-2","journal-title":"Immunity"},{"key":"9202_CR161","doi-asserted-by":"publisher","first-page":"1726565","DOI":"10.3389\/fimmu.2026.1726565","volume":"17","author":"AB Schultz","year":"2026","unstructured":"Schultz AB, Dalzell M, Nivelo L et al (2026) T-cell lymphoma-associated STAT3 variants impose a type 1 regulatory-like phenotype. Front Immunol 17:1726565. https:\/\/doi.org\/10.3389\/fimmu.2026.1726565","journal-title":"Front Immunol"},{"key":"9202_CR162","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41408-024-00977-0","volume":"14","author":"G Semenzato","year":"2024","unstructured":"Semenzato G, Calabretto G, Teramo A et al (2024) The constitutive activation of STAT3 gene and its mutations are at the crossroad between LGL leukemia and autoimmune disorders. Blood Cancer J 14:13. https:\/\/doi.org\/10.1038\/s41408-024-00977-0","journal-title":"Blood Cancer J"},{"key":"9202_CR163","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1093\/cei\/uxad007","volume":"212","author":"J Mackie","year":"2023","unstructured":"Mackie J, Ma CS, Tangye SG, Guerin A (2023) The ups and downs of STAT3 function: too much, too little and human immune dysregulation. Clin Exp Immunol 212:107\u2013116. https:\/\/doi.org\/10.1093\/cei\/uxad007","journal-title":"Clin Exp Immunol"},{"key":"9202_CR164","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.bbrc.2018.05.042","volume":"501","author":"L Bai","year":"2018","unstructured":"Bai L, Fang H, Xia S et al (2018) STAT1 activation represses IL-22 gene expression and psoriasis pathogenesis. Biochem Biophys Res Commun 501:563\u2013569. https:\/\/doi.org\/10.1016\/j.bbrc.2018.05.042","journal-title":"Biochem Biophys Res Commun"},{"key":"9202_CR165","doi-asserted-by":"publisher","first-page":"3779","DOI":"10.4049\/jimmunol.1303076","volume":"193","author":"I Backert","year":"2014","unstructured":"Backert I, Koralov SB, Wirtz S et al (2014) STAT3 activation in Th17 and Th22 cells controls IL-22-mediated epithelial host defense during infectious colitis. J Immunol 193:3779\u20133791. https:\/\/doi.org\/10.4049\/jimmunol.1303076","journal-title":"J Immunol"},{"key":"9202_CR166","doi-asserted-by":"publisher","first-page":"8137","DOI":"10.1073\/pnas.0600666103","volume":"103","author":"Z Chen","year":"2006","unstructured":"Chen Z, Laurence A, Kanno Y et al (2006) Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells. Proc Natl Acad Sci U S A 103:8137\u20138142. https:\/\/doi.org\/10.1073\/pnas.0600666103","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9202_CR167","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/ni938","volume":"4","author":"H Yasukawa","year":"2003","unstructured":"Yasukawa H, Ohishi M, Mori H et al (2003) IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages. Nat Immunol 4:551\u2013556. https:\/\/doi.org\/10.1038\/ni938","journal-title":"Nat Immunol"},{"key":"9202_CR168","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3389\/fimmu.2012.00020","volume":"3","author":"A Yoshimura","year":"2012","unstructured":"Yoshimura A, Suzuki M, Sakaguchi R et al (2012) SOCS, Inflammation, and Autoimmunity. Front Immunol 3:20. https:\/\/doi.org\/10.3389\/fimmu.2012.00020","journal-title":"Front Immunol"},{"key":"9202_CR169","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","volume":"126","author":"II Ivanov","year":"2006","unstructured":"Ivanov II, McKenzie BS, Zhou L et al (2006) The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17\u2009+\u2009T helper cells. Cell 126:1121\u20131133. https:\/\/doi.org\/10.1016\/j.cell.2006.07.035","journal-title":"Cell"},{"key":"9202_CR170","doi-asserted-by":"publisher","first-page":"4870","DOI":"10.1038\/s41467-018-07203-z","volume":"9","author":"Z He","year":"2018","unstructured":"He Z, Zhang J, Huang Z et al (2018) Sumoylation of ROR\u03b3t regulates TH17 differentiation and thymocyte development. Nat Commun 9:4870. https:\/\/doi.org\/10.1038\/s41467-018-07203-z","journal-title":"Nat Commun"},{"key":"9202_CR171","doi-asserted-by":"publisher","first-page":"e0181868","DOI":"10.1371\/journal.pone.0181868","volume":"12","author":"G Castro","year":"2017","unstructured":"Castro G, Liu X, Ngo K et al (2017) ROR\u03b3t and ROR\u03b1 signature genes in human Th17 cells. PLoS ONE 12:e0181868. https:\/\/doi.org\/10.1371\/journal.pone.0181868","journal-title":"PLoS ONE"},{"key":"9202_CR172","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.0105-2896.2009.00864.x","volume":"233","author":"PS Biswas","year":"2010","unstructured":"Biswas PS, Bhagat G, Pernis AB (2010) IRF4 and its regulators: evolving insights into the pathogenesis of inflammatory arthritis? Immunol Rev 233:79\u201396. https:\/\/doi.org\/10.1111\/j.0105-2896.2009.00864.x","journal-title":"Immunol Rev"},{"key":"9202_CR173","doi-asserted-by":"publisher","first-page":"283","DOI":"10.4103\/ejdv.ejdv_62_24","volume":"45","author":"NW Mikhael","year":"2025","unstructured":"Mikhael NW, Abdelazeem SE, Mohammed SA, Elhabak DM (2025) Retinoid acid-related orphan receptor alpha serum level and gene polymorphism in psoriatic patient. Egypt J Dermatology Venereol 45:283\u2013292. https:\/\/doi.org\/10.4103\/ejdv.ejdv_62_24","journal-title":"Egypt J Dermatology Venereol"},{"key":"9202_CR174","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.immuni.2007.11.016","volume":"28","author":"XO Yang","year":"2008","unstructured":"Yang XO, Pappu BP, Nurieva R et al (2008) T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. Immunity 28:29\u201339. https:\/\/doi.org\/10.1016\/j.immuni.2007.11.016","journal-title":"Immunity"},{"key":"9202_CR175","doi-asserted-by":"publisher","first-page":"7091","DOI":"10.2147\/JIR.S344031","volume":"14","author":"C-C Ho","year":"2021","unstructured":"Ho C-C, Kim G, Mun CH et al (2021) Transcriptional Interactomic Inhibition of ROR\u03b1 Suppresses Th17-Related Inflammation. J Inflamm Res 14:7091\u20137105. https:\/\/doi.org\/10.2147\/JIR.S344031","journal-title":"J Inflamm Res"},{"key":"9202_CR176","doi-asserted-by":"publisher","first-page":"eabn7774","DOI":"10.1126\/sciadv.abn7774","volume":"8","author":"X Chi","year":"2022","unstructured":"Chi X, Jin W, Zhao X et al (2022) ROR\u03b3t expression in mature TH17 cells safeguards their lineage specification by inhibiting conversion to TH2 cells. Sci Adv 8:eabn7774. https:\/\/doi.org\/10.1126\/sciadv.abn7774","journal-title":"Sci Adv"},{"key":"9202_CR177","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1016\/j.immuni.2022.09.013","volume":"55","author":"JA Hall","year":"2022","unstructured":"Hall JA, Pokrovskii M, Kroehling L et al (2022) Transcription factor ROR\u03b1 enforces stability of the Th17 cell effector program by binding to a Rorc cis-regulatory element. Immunity 55:2027\u20132043 .e9. https:\/\/doi.org\/10.1016\/j.immuni.2022.09.013","journal-title":"Immunity"},{"key":"9202_CR178","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41467-020-20385-9","volume":"12","author":"R Wang","year":"2021","unstructured":"Wang R, Campbell S, Amir M et al (2021) Genetic and pharmacological inhibition of the nuclear receptor ROR\u03b1 regulates TH17 driven inflammatory disorders. Nat Commun 12:76. https:\/\/doi.org\/10.1038\/s41467-020-20385-9","journal-title":"Nat Commun"},{"key":"9202_CR179","doi-asserted-by":"publisher","first-page":"114951","DOI":"10.1016\/j.celrep.2024.114951","volume":"43","author":"X Zhong","year":"2024","unstructured":"Zhong X, Wu H, Zhang W et al (2024) Distinct ROR\u03b3t-dependent Th17 immune responses are required for autoimmune pathogenesis and protection against bacterial infection. Cell Rep 43:114951. https:\/\/doi.org\/10.1016\/j.celrep.2024.114951","journal-title":"Cell Rep"},{"key":"9202_CR180","doi-asserted-by":"publisher","first-page":"7423","DOI":"10.4049\/jimmunol.180.11.7423","volume":"180","author":"J P\u00e8ne","year":"2008","unstructured":"P\u00e8ne J, Chevalier S, Preisser L et al (2008) Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes. J Immunol 180:7423\u20137430. https:\/\/doi.org\/10.4049\/jimmunol.180.11.7423","journal-title":"J Immunol"},{"key":"9202_CR181","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.immuni.2014.01.002","volume":"40","author":"Y Wang","year":"2014","unstructured":"Wang Y, Godec J, Ben-Aissa K et al (2014) The transcription factors T-bet and Runx are required for the ontogeny of pathogenic interferon-\u03b3-producing T helper 17 cells. Immunity 40:355\u2013366. https:\/\/doi.org\/10.1016\/j.immuni.2014.01.002","journal-title":"Immunity"},{"key":"9202_CR182","doi-asserted-by":"publisher","first-page":"4606","DOI":"10.3892\/mmr.2016.5108","volume":"13","author":"D Fu","year":"2016","unstructured":"Fu D, Song X, Hu H et al (2016) Downregulation of RUNX3 moderates the frequency of Th17 and Th22 cells in patients with psoriasis. Mol Med Rep 13:4606\u20134612. https:\/\/doi.org\/10.3892\/mmr.2016.5108","journal-title":"Mol Med Rep"},{"key":"9202_CR183","doi-asserted-by":"publisher","first-page":"3198","DOI":"10.4049\/jimmunol.1800672","volume":"202","author":"M Sekimata","year":"2019","unstructured":"Sekimata M, Yoshida D, Araki A et al (2019) Runx1 and ROR\u03b3t Cooperate to Upregulate IL-22 Expression in Th Cells through Its Distal Enhancer. J Immunol 202:3198\u20133210. https:\/\/doi.org\/10.4049\/jimmunol.1800672","journal-title":"J Immunol"},{"key":"9202_CR184","doi-asserted-by":"publisher","first-page":"688066","DOI":"10.3389\/fimmu.2021.688066","volume":"12","author":"Q Jiang","year":"2021","unstructured":"Jiang Q, Yang G, Xiao F et al (2021) Role of Th22 Cells in the Pathogenesis of Autoimmune Diseases. Front Immunol 12:688066. https:\/\/doi.org\/10.3389\/fimmu.2021.688066","journal-title":"Front Immunol"},{"key":"9202_CR185","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/mi.2015.74","volume":"9","author":"B-H Yang","year":"2016","unstructured":"Yang B-H, Hagemann S, Mamareli P et al (2016) Foxp3(+) T cells expressing ROR\u03b3t represent a stable regulatory T-cell effector lineage with enhanced suppressive capacity during intestinal inflammation. Mucosal Immunol 9:444\u2013457. https:\/\/doi.org\/10.1038\/mi.2015.74","journal-title":"Mucosal Immunol"},{"key":"9202_CR186","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.celrep.2017.09.021","volume":"21","author":"B-S Kim","year":"2017","unstructured":"Kim B-S, Lu H, Ichiyama K et al (2017) Generation of ROR\u03b3t+ Antigen-Specific T Regulatory 17 Cells from Foxp3\u2009+\u2009Precursors in Autoimmunity. Cell Rep 21:195\u2013207. https:\/\/doi.org\/10.1016\/j.celrep.2017.09.021","journal-title":"Cell Rep"},{"key":"9202_CR187","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1007\/s00109-018-1706-x","volume":"96","author":"J Yang","year":"2018","unstructured":"Yang J, Zou M, Pezoldt J et al (2018) Thymus-derived Foxp3\u2009+\u2009regulatory T cells upregulate ROR\u03b3t expression under inflammatory conditions. J Mol Med (Berl) 96:1387\u20131394. https:\/\/doi.org\/10.1007\/s00109-018-1706-x","journal-title":"J Mol Med (Berl)"},{"key":"9202_CR188","doi-asserted-by":"publisher","first-page":"110520","DOI":"10.1016\/j.celrep.2022.110520","volume":"38","author":"S Ma","year":"2022","unstructured":"Ma S, Patel SA, Abe Y et al (2022) ROR\u03b3t phosphorylation protects against T cell-mediated inflammation. Cell Rep 38:110520. https:\/\/doi.org\/10.1016\/j.celrep.2022.110520","journal-title":"Cell Rep"},{"key":"9202_CR189","doi-asserted-by":"publisher","first-page":"20675","DOI":"10.1038\/s41598-022-24924-w","volume":"12","author":"JN Pouw","year":"2022","unstructured":"Pouw JN, Olde Nordkamp MAM, van Kempen T et al (2022) Regulatory T cells in psoriatic arthritis: an IL-17A-producing, Foxp3intCD161\u2009+\u2009ROR\u03b3t\u2009+\u2009ICOS\u2009+\u2009phenotype, that associates with the presence of ADAMTSL5 autoantibodies. Sci Rep 12:20675. https:\/\/doi.org\/10.1038\/s41598-022-24924-w","journal-title":"Sci Rep"},{"key":"9202_CR190","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.1093\/rheumatology\/kead022","volume":"62","author":"C Mortier","year":"2023","unstructured":"Mortier C, Gracey E, Coudenys J et al (2023) ROR\u03b3t inhibition ameliorates IL-23 driven experimental psoriatic arthritis by predominantly modulating \u03b3\u03b4-T cells. Rheumatology (Oxford) 62:3169\u20133178. https:\/\/doi.org\/10.1093\/rheumatology\/kead022","journal-title":"Rheumatology (Oxford)"},{"key":"9202_CR191","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.3389\/fimmu.2018.01210","volume":"9","author":"L Tang","year":"2018","unstructured":"Tang L, Yang X, Liang Y et al (2018) Transcription Factor Retinoid-Related Orphan Receptor \u03b3t: A Promising Target for the Treatment of Psoriasis. Front Immunol 9:1210. https:\/\/doi.org\/10.3389\/fimmu.2018.01210","journal-title":"Front Immunol"},{"key":"9202_CR192","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41467-018-07911-6","volume":"10","author":"K Venken","year":"2019","unstructured":"Venken K, Jacques P, Mortier C et al (2019) ROR\u03b3t inhibition selectively targets IL-17 producing iNKT and \u03b3\u03b4-T cells enriched in Spondyloarthritis patients. Nat Commun 10:9. https:\/\/doi.org\/10.1038\/s41467-018-07911-6","journal-title":"Nat Commun"},{"key":"9202_CR193","doi-asserted-by":"publisher","first-page":"37977","DOI":"10.1038\/srep37977","volume":"6","author":"X Xue","year":"2016","unstructured":"Xue X, Soroosh P, De Leon-Tabaldo A et al (2016) Pharmacologic modulation of ROR\u03b3t translates to efficacy in preclinical and translational models of psoriasis and inflammatory arthritis. Sci Rep 6:37977. https:\/\/doi.org\/10.1038\/srep37977","journal-title":"Sci Rep"},{"key":"9202_CR194","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1016\/j.jid.2025.03.036","volume":"145","author":"H Akbarialiabad","year":"2025","unstructured":"Akbarialiabad H, Bunick CG (2025) Revisiting ROR\u03b3t Inhibition in Plaque Psoriasis: Lessons Learned from BI 730357. J Invest Dermatol 145:1831\u20131834. https:\/\/doi.org\/10.1016\/j.jid.2025.03.036","journal-title":"J Invest Dermatol"},{"key":"9202_CR195","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1002\/ibd.21476","volume":"17","author":"J Mudter","year":"2011","unstructured":"Mudter J, Yu J, Zufferey C et al (2011) IRF4 regulates IL-17A promoter activity and controls ROR\u03b3t-dependent Th17 colitis in vivo. Inflamm Bowel Dis 17:1343\u20131358. https:\/\/doi.org\/10.1002\/ibd.21476","journal-title":"Inflamm Bowel Dis"},{"key":"9202_CR196","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1126\/science.1228309","volume":"338","author":"E Glasmacher","year":"2012","unstructured":"Glasmacher E, Agrawal S, Chang AB et al (2012) A genomic regulatory element that directs assembly and function of immune-specific AP-1-IRF complexes. Science 338:975\u2013980. https:\/\/doi.org\/10.1126\/science.1228309","journal-title":"Science"},{"key":"9202_CR197","doi-asserted-by":"publisher","first-page":"20846","DOI":"10.1073\/pnas.0809077106","volume":"105","author":"M Huber","year":"2008","unstructured":"Huber M, Br\u00fcstle A, Reinhard K et al (2008) IRF4 is essential for IL-21-mediated induction, amplification, and stabilization of the Th17 phenotype. Proc Natl Acad Sci U S A 105:20846\u201320851. https:\/\/doi.org\/10.1073\/pnas.0809077106","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9202_CR198","doi-asserted-by":"publisher","first-page":"3280","DOI":"10.1172\/JCI42856","volume":"120","author":"PS Biswas","year":"2010","unstructured":"Biswas PS, Gupta S, Chang E et al (2010) Phosphorylation of IRF4 by ROCK2 regulates IL-17 and IL-21 production and the development of autoimmunity in mice. J Clin Invest 120:3280\u20133295. https:\/\/doi.org\/10.1172\/JCI42856","journal-title":"J Clin Invest"},{"key":"9202_CR199","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s11596-012-0050-6","volume":"32","author":"A Ni","year":"2012","unstructured":"Ni A, Chen H, Wu Y et al (2012) Expression of IRF-4 and IBP in skin lesions of patients with psoriasis vulgaris. J Huazhong Univ Sci Technolog Med Sci 32:287\u2013290. https:\/\/doi.org\/10.1007\/s11596-012-0050-6","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"9202_CR200","doi-asserted-by":"publisher","first-page":"3809","DOI":"10.4049\/jimmunol.1602142","volume":"198","author":"A Zanin-Zhorov","year":"2017","unstructured":"Zanin-Zhorov A, Weiss JM, Trzeciak A et al (2017) Cutting Edge: Selective Oral ROCK2 Inhibitor Reduces Clinical Scores in Patients with Psoriasis Vulgaris and Normalizes Skin Pathology via Concurrent Regulation of IL-17 and IL-10. J Immunol 198:3809\u20133814. https:\/\/doi.org\/10.4049\/jimmunol.1602142","journal-title":"J Immunol"},{"key":"9202_CR201","doi-asserted-by":"publisher","first-page":"16814","DOI":"10.1073\/pnas.1414189111","volume":"111","author":"A Zanin-Zhorov","year":"2014","unstructured":"Zanin-Zhorov A, Weiss JM, Nyuydzefe MS et al (2014) Selective oral ROCK2 inhibitor down-regulates IL-21 and IL-17 secretion in human T cells via STAT3-dependent mechanism. Proc Natl Acad Sci U S A 111:16814\u201316819. https:\/\/doi.org\/10.1073\/pnas.1414189111","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9202_CR202","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.immuni.2017.09.001","volume":"47","author":"V Krishnamoorthy","year":"2017","unstructured":"Krishnamoorthy V, Kannanganat S, Maienschein-Cline M et al (2017) The IRF4 Gene Regulatory Module Functions as a Read-Write Integrator to Dynamically Coordinate T Helper Cell Fate. Immunity 47:481\u2013497e7. https:\/\/doi.org\/10.1016\/j.immuni.2017.09.001","journal-title":"Immunity"},{"key":"9202_CR203","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s00403-022-02379-3","volume":"315","author":"LCO da Costa","year":"2023","unstructured":"da Costa LCO, Gardinassi LG, Veras FP et al (2023) Expression of B lymphocyte-induced maturation protein 1 (Blimp-1) in keratinocyte and cytokine signalling drives human Th17 response in psoriasis. Arch Dermatol Res 315:481\u2013490. https:\/\/doi.org\/10.1007\/s00403-022-02379-3","journal-title":"Arch Dermatol Res"},{"key":"9202_CR204","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.3390\/ijms22052775","volume":"22","author":"M Kang","year":"2021","unstructured":"Kang M, Lee H-S, Choi JK et al (2021) Deletion of Irf4 in T Cells Suppressed Autoimmune Uveitis and Dysregulated Transcriptional Programs Linked to CD4\u2009+\u2009T Cell Differentiation and Metabolism. Int J Mol Sci 22:2775. https:\/\/doi.org\/10.3390\/ijms22052775","journal-title":"Int J Mol Sci"},{"key":"9202_CR205","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/j.immuni.2017.11.003","volume":"47","author":"J Wu","year":"2017","unstructured":"Wu J, Zhang H, Shi X et al (2017) Ablation of Transcription Factor IRF4 Promotes Transplant Acceptance by Driving Allogenic CD4\u2009+\u2009T Cell Dysfunction. Immunity 47:1114\u20131128e6. https:\/\/doi.org\/10.1016\/j.immuni.2017.11.003","journal-title":"Immunity"},{"key":"9202_CR206","doi-asserted-by":"publisher","first-page":"3575","DOI":"10.1016\/j.apsb.2025.05.004","volume":"15","author":"Y Yu","year":"2025","unstructured":"Yu Y, Wang Y, Chen W et al (2025) Antisense oligonucleotides targeting IRF4 alleviate psoriasis. Acta Pharm Sin B 15:3575\u20133590. https:\/\/doi.org\/10.1016\/j.apsb.2025.05.004","journal-title":"Acta Pharm Sin B"},{"key":"9202_CR207","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.immuni.2008.10.011","volume":"29","author":"Q Chen","year":"2008","unstructured":"Chen Q, Yang W, Gupta S et al (2008) IRF-4-binding protein inhibits interleukin-17 and interleukin-21 production by controlling the activity of IRF-4 transcription factor. Immunity 29:899\u2013911. https:\/\/doi.org\/10.1016\/j.immuni.2008.10.011","journal-title":"Immunity"},{"key":"9202_CR208","doi-asserted-by":"publisher","first-page":"15366","DOI":"10.1038\/ncomms15366","volume":"8","author":"L Campos Carrascosa","year":"2017","unstructured":"Campos Carrascosa L, Klein M, Kitagawa Y et al (2017) Reciprocal regulation of the Il9 locus by counteracting activities of transcription factors IRF1 and IRF4. Nat Commun 8:15366. https:\/\/doi.org\/10.1038\/ncomms15366","journal-title":"Nat Commun"},{"key":"9202_CR209","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.immuni.2010.07.014","volume":"33","author":"V Staudt","year":"2010","unstructured":"Staudt V, Bothur E, Klein M et al (2010) Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells. Immunity 33:192\u2013202. https:\/\/doi.org\/10.1016\/j.immuni.2010.07.014","journal-title":"Immunity"},{"key":"9202_CR210","doi-asserted-by":"publisher","first-page":"11808","DOI":"10.1073\/pnas.182425099","volume":"99","author":"M Lohoff","year":"2002","unstructured":"Lohoff M, Mittr\u00fccker H-W, Prechtl S et al (2002) Dysregulated T helper cell differentiation in the absence of interferon regulatory factor 4. Proc Natl Acad Sci U S A 99:11808\u201311812. https:\/\/doi.org\/10.1073\/pnas.182425099","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9202_CR211","doi-asserted-by":"publisher","first-page":"35521","DOI":"10.1038\/srep35521","volume":"6","author":"J Mahnke","year":"2016","unstructured":"Mahnke J, Schumacher V, Ahrens S et al (2016) Interferon Regulatory Factor 4 controls TH1 cell effector function and metabolism. Sci Rep 6:35521. https:\/\/doi.org\/10.1038\/srep35521","journal-title":"Sci Rep"},{"key":"9202_CR212","doi-asserted-by":"publisher","first-page":"156","DOI":"10.4049\/immunohorizons.1700012","volume":"1","author":"R Kratchmarov","year":"2017","unstructured":"Kratchmarov R, Nish SA, Lin W-HW et al (2017) IRF4 Couples Anabolic Metabolism to Th1 Cell Fate Determination. Immunohorizons 1:156\u2013161. https:\/\/doi.org\/10.4049\/immunohorizons.1700012","journal-title":"Immunohorizons"},{"key":"9202_CR213","doi-asserted-by":"publisher","first-page":"115407","DOI":"10.1016\/j.celrep.2025.115407","volume":"44","author":"A Gabele","year":"2025","unstructured":"Gabele A, Sprang M, Cihan M et al (2025) Unveiling IRF4-steered regulation of context-dependent effector programs in CD4\u2009+\u2009T cells under Th17- and Treg-skewing conditions. Cell Rep 44:115407. https:\/\/doi.org\/10.1016\/j.celrep.2025.115407","journal-title":"Cell Rep"},{"key":"9202_CR214","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1172\/JCI130426","volume":"130","author":"G Alvisi","year":"2020","unstructured":"Alvisi G, Brummelman J, Puccio S et al (2020) IRF4 instructs effector Treg differentiation and immune suppression in human cancer. J Clin Invest 130:3137\u20133150. https:\/\/doi.org\/10.1172\/JCI130426","journal-title":"J Clin Invest"},{"key":"9202_CR215","doi-asserted-by":"publisher","first-page":"e49416","DOI":"10.7554\/eLife.49416","volume":"9","author":"J Lee","year":"2020","unstructured":"Lee J, Zhang J, Chung Y-J et al (2020) Inhibition of IRF4 in dendritic cells by PRR-independent and -dependent signals inhibit Th2 and promote Th17 responses. Elife 9:e49416. https:\/\/doi.org\/10.7554\/eLife.49416","journal-title":"Elife"},{"key":"9202_CR216","doi-asserted-by":"publisher","first-page":"13004","DOI":"10.3390\/ijms222313004","volume":"22","author":"R Queiro","year":"2021","unstructured":"Queiro R, Coto P, Gonz\u00e1lez-Lara L, Coto E (2021) Genetic Variants of the NF-\u03baB Pathway: Unraveling the Genetic Architecture of Psoriatic Disease. Int J Mol Sci 22:13004. https:\/\/doi.org\/10.3390\/ijms222313004","journal-title":"Int J Mol Sci"},{"key":"9202_CR217","doi-asserted-by":"publisher","first-page":"1762269","DOI":"10.3389\/fimmu.2025.1762269","volume":"16","author":"Y Lin","year":"2025","unstructured":"Lin Y, Chen J, Du H et al (2025) Activation of NF-\u03baB signaling in tissue-resident memory T cells promotes recurrent psoriasis in mice. Front Immunol 16:1762269. https:\/\/doi.org\/10.3389\/fimmu.2025.1762269","journal-title":"Front Immunol"},{"key":"9202_CR218","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.jid.2024.08.006","volume":"145","author":"Y Qiu","year":"2025","unstructured":"Qiu Y, Jiang W, Feng D et al (2025) Resolving 3-Dimensional Genomic Landscape of CD4\u2009+\u2009T Cells in the Peripheral Blood of Patients with Psoriasis. J Invest Dermatol 145:831\u2013841e10. https:\/\/doi.org\/10.1016\/j.jid.2024.08.006","journal-title":"J Invest Dermatol"},{"key":"9202_CR219","doi-asserted-by":"publisher","first-page":"4741","DOI":"10.1038\/s41467-021-25066-9","volume":"12","author":"R Andres-Ejarque","year":"2021","unstructured":"Andres-Ejarque R, Ale HB, Grys K et al (2021) Enhanced NF-\u03baB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasis. Nat Commun 12:4741. https:\/\/doi.org\/10.1038\/s41467-021-25066-9","journal-title":"Nat Commun"},{"key":"9202_CR220","doi-asserted-by":"publisher","first-page":"105452","DOI":"10.1016\/j.ebiom.2024.105452","volume":"110","author":"AR Liu","year":"2024","unstructured":"Liu AR, Sarkar N, Cress JD et al (2024) NF-\u03baB c-Rel is a critical regulator of TLR7-induced inflammation in psoriasis. EBioMedicine 110:105452. https:\/\/doi.org\/10.1016\/j.ebiom.2024.105452","journal-title":"EBioMedicine"},{"key":"9202_CR221","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1016\/j.jid.2021.11.004","volume":"142","author":"K Suzuki","year":"2022","unstructured":"Suzuki K, Suzuki K, Yabe Y et al (2022) NF-\u03baB1 Contributes to Imiquimod-Induced Psoriasis-Like Skin Inflammation by Inducing V\u03b34\u2009+\u2009V\u03b44\u2009+\u2009\u03b3\u03b4T17 Cells. J Invest Dermatol 142:1639\u20131649e5. https:\/\/doi.org\/10.1016\/j.jid.2021.11.004","journal-title":"J Invest Dermatol"},{"key":"9202_CR222","doi-asserted-by":"publisher","first-page":"18529","DOI":"10.1073\/pnas.1204557109","volume":"109","author":"LL Molinero","year":"2012","unstructured":"Molinero LL, Cubre A, Mora-Solano C et al (2012) T cell receptor\/CARMA1\/NF-\u03baB signaling controls T-helper (Th) 17 differentiation. Proc Natl Acad Sci U S A 109:18529\u201318534. https:\/\/doi.org\/10.1073\/pnas.1204557109","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9202_CR223","doi-asserted-by":"publisher","first-page":"14","DOI":"10.4110\/in.2014.14.1.14","volume":"14","author":"S-H Park","year":"2014","unstructured":"Park S-H, Cho G, Park S-G (2014) NF-\u03baB Activation in T Helper 17 Cell Differentiation. Immune Netw 14:14\u201320. https:\/\/doi.org\/10.4110\/in.2014.14.1.14","journal-title":"Immune Netw"},{"key":"9202_CR224","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1111\/exd.14871","volume":"32","author":"X Jiang","year":"2023","unstructured":"Jiang X, Shi R, Ma R et al (2023) The role of microRNA in psoriasis: A review. Exp Dermatol 32:1598\u20131612. https:\/\/doi.org\/10.1111\/exd.14871","journal-title":"Exp Dermatol"},{"key":"9202_CR225","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1111\/exd.14332","volume":"30","author":"C Zeng","year":"2021","unstructured":"Zeng C, Tsoi LC, Gudjonsson JE (2021) Dysregulated epigenetic modifications in psoriasis. Exp Dermatol 30:1156\u20131166. https:\/\/doi.org\/10.1111\/exd.14332","journal-title":"Exp Dermatol"},{"key":"9202_CR226","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3390\/ncrna11050069","volume":"11","author":"J Danis","year":"2025","unstructured":"Danis J, Sz\u00e9ll M (2025) Long Non-Coding RNAs in Psoriasis: A Comprehensive Review of Expression Profiles, Mechanistic Insights, Genetic Associations, and Their Clinical Implications. Noncoding RNA 11:69. https:\/\/doi.org\/10.3390\/ncrna11050069","journal-title":"Noncoding RNA"},{"key":"9202_CR227","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.3390\/cells9122656","volume":"9","author":"S Domingo","year":"2020","unstructured":"Domingo S, Sol\u00e9 C, Molin\u00e9 T et al (2020) MicroRNAs in Several Cutaneous Autoimmune Diseases: Psoriasis, Cutaneous Lupus Erythematosus and Atopic Dermatitis. Cells 9:2656. https:\/\/doi.org\/10.3390\/cells9122656","journal-title":"Cells"},{"key":"9202_CR228","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ncrna.2020.06.002","volume":"5","author":"S Ghafouri-Fard","year":"2020","unstructured":"Ghafouri-Fard S, Eghtedarian R, Taheri M, Rakhshan A (2020) The eminent roles of ncRNAs in the pathogenesis of psoriasis. Noncoding RNA Res 5:99\u2013108. https:\/\/doi.org\/10.1016\/j.ncrna.2020.06.002","journal-title":"Noncoding RNA Res"},{"key":"9202_CR229","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s10142-023-01057-5","volume":"23","author":"D Ghosh","year":"2023","unstructured":"Ghosh D, Ganguly T, Chatterjee R (2023) Emerging roles of non-coding RNAs in psoriasis pathogenesis. Funct Integr Genomics 23:129. https:\/\/doi.org\/10.1007\/s10142-023-01057-5","journal-title":"Funct Integr Genomics"},{"key":"9202_CR230","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3390\/ncrna11010007","volume":"11","author":"K Kie\u0142bowski","year":"2025","unstructured":"Kie\u0142bowski K, J\u0119drasiak A, Bakinowska E, Pawlik A (2025) The Role of Long Non-Coding RNA in the Pathogenesis of Psoriasis. Noncoding RNA 11:7. https:\/\/doi.org\/10.3390\/ncrna11010007","journal-title":"Noncoding RNA"},{"key":"9202_CR231","doi-asserted-by":"publisher","first-page":"1695894","DOI":"10.3389\/fimmu.2025.1695894","volume":"16","author":"S Prasad","year":"2025","unstructured":"Prasad S, Adivikolanu H, Banerjee A et al (2025) The role of microRNAs and long non-coding RNAs in epigenetic regulation of T cells: implications for autoimmunity. Front Immunol 16:1695894. https:\/\/doi.org\/10.3389\/fimmu.2025.1695894","journal-title":"Front Immunol"},{"key":"9202_CR232","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1080\/15476286.2023.2223486","volume":"20","author":"R Shi","year":"2023","unstructured":"Shi R, Ma R, Jiang X et al (2023) Implications of LncRNAs and CircRNAs in psoriasis: a review. RNA Biol 20:334\u2013347. https:\/\/doi.org\/10.1080\/15476286.2023.2223486","journal-title":"RNA Biol"},{"key":"9202_CR233","doi-asserted-by":"publisher","first-page":"150081","DOI":"10.1016\/j.gene.2026.150081","volume":"990","author":"H Singh","year":"2026","unstructured":"Singh H, Jha H, Taliyan R (2026) Regulatory roles of microRNAs in epigenetic and immune gene networks in psoriasis. Gene 990:150081. https:\/\/doi.org\/10.1016\/j.gene.2026.150081","journal-title":"Gene"},{"key":"9202_CR234","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3390\/ncrna11010016","volume":"11","author":"LTK Teo","year":"2025","unstructured":"Teo LTK, Juantuah-Kusi N, Subramanian G, Sampath P (2025) Psoriasis Treatments: Emerging Roles and Future Prospects of MicroRNAs. Noncoding RNA 11:16. https:\/\/doi.org\/10.3390\/ncrna11010016","journal-title":"Noncoding RNA"},{"key":"9202_CR235","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1002\/eji.201444633","volume":"45","author":"C Haftmann","year":"2015","unstructured":"Haftmann C, Stittrich A-B, Zimmermann J et al (2015) miR-148a is upregulated by Twist1 and T-bet and promotes Th1-cell survival by regulating the proapoptotic gene Bim. Eur J Immunol 45:1192\u20131205. https:\/\/doi.org\/10.1002\/eji.201444633","journal-title":"Eur J Immunol"},{"key":"9202_CR236","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.3389\/fimmu.2017.01932","volume":"8","author":"S Alivernini","year":"2017","unstructured":"Alivernini S, Gremese E, McSharry C et al (2017) MicroRNA-155-at the Critical Interface of Innate and Adaptive Immunity in Arthritis. Front Immunol 8:1932. https:\/\/doi.org\/10.3389\/fimmu.2017.01932","journal-title":"Front Immunol"},{"key":"9202_CR237","doi-asserted-by":"publisher","first-page":"e76217","DOI":"10.1371\/journal.pone.0076217","volume":"8","author":"K Smigielska-Czepiel","year":"2013","unstructured":"Smigielska-Czepiel K, van den Berg A, Jellema P et al (2013) Dual role of miR-21 in CD4\u2009+\u2009T-cells: activation-induced miR-21 supports survival of memory T-cells and regulates CCR7 expression in naive T-cells. PLoS ONE 8:e76217. https:\/\/doi.org\/10.1371\/journal.pone.0076217","journal-title":"PLoS ONE"},{"key":"9202_CR238","doi-asserted-by":"publisher","first-page":"W154","DOI":"10.1093\/nar\/gkad431","volume":"51","author":"S Tastsoglou","year":"2023","unstructured":"Tastsoglou S, Skoufos G, Miliotis M et al (2023) DIANA-miRPath v4.0: expanding target-based miRNA functional analysis in cell-type and tissue contexts. Nucleic Acids Res 51:W154\u2013W159. https:\/\/doi.org\/10.1093\/nar\/gkad431","journal-title":"Nucleic Acids Res"},{"key":"9202_CR239","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.70459","author":"T Torres-Moral","year":"2026","unstructured":"Torres-Moral T, Riera-Monroig J, Tell-Mart\u00ed G et al (2026) Transcriptomic meta-analysis identifies core molecular pathways in plaque psoriasis. J Eur Acad Dermatol Venereol. https:\/\/doi.org\/10.1111\/jdv.70459","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"9202_CR240","doi-asserted-by":"publisher","first-page":"11877","DOI":"10.3390\/ijms231911877","volume":"23","author":"ME Kim","year":"2022","unstructured":"Kim ME, Kim DH, Lee JS (2022) FoxO Transcription Factors: Applicability as a Novel Immune Cell Regulators and Therapeutic Targets in Oxidative Stress-Related Diseases. Int J Mol Sci 23:11877. https:\/\/doi.org\/10.3390\/ijms231911877","journal-title":"Int J Mol Sci"},{"key":"9202_CR241","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1016\/j.jid.2018.12.035","volume":"139","author":"B Li","year":"2019","unstructured":"Li B, Lei J, Yang L et al (2019) Dysregulation of Akt-FOXO1 Pathway Leads to Dysfunction of Regulatory T Cells in Patients with Psoriasis. J Invest Dermatol 139:2098\u20132107. https:\/\/doi.org\/10.1016\/j.jid.2018.12.035","journal-title":"J Invest Dermatol"},{"key":"9202_CR242","first-page":"799","volume":"13","author":"Z Fan","year":"2020","unstructured":"Fan Z, Li L, Wang X, Miao G (2020) Dysfunction of regulatory T cells mediated by AKT-FOXO1 signaling pathway occurs during the development of psoriasis. Int J Clin Exp Pathol 13:799\u2013809","journal-title":"Int J Clin Exp Pathol"},{"key":"9202_CR243","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1111\/phpp.12790","volume":"38","author":"AA Eid","year":"2022","unstructured":"Eid AA, Aly RG, Elkholy SAE, Sorour OA (2022) Influence of narrow-band ultraviolet B therapy on sirtuin 1 expression in lesional skin of patients with chronic plaque psoriasis: Relation to clinical improvement and interferon-\u03b3 expression. Photodermatol Photoimmunol Photomed 38:555\u2013563. https:\/\/doi.org\/10.1111\/phpp.12790","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"9202_CR244","doi-asserted-by":"publisher","first-page":"102476","DOI":"10.1016\/j.genrep.2026.102476","volume":"43","author":"A Shafi","year":"2026","unstructured":"Shafi A, Khan MN, Gulati P (2026) SIRT1-mediated regulation of inflammation and keratinocyte function in psoriasis. Gene Rep 43:102476. https:\/\/doi.org\/10.1016\/j.genrep.2026.102476","journal-title":"Gene Rep"},{"key":"9202_CR245","doi-asserted-by":"publisher","first-page":"D239","DOI":"10.1093\/nar\/gkx1141","volume":"46","author":"D Karagkouni","year":"2018","unstructured":"Karagkouni D, Paraskevopoulou MD, Chatzopoulos S et al (2018) DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA-gene interactions. Nucleic Acids Res 46:D239\u2013D245. https:\/\/doi.org\/10.1093\/nar\/gkx1141","journal-title":"Nucleic Acids Res"},{"key":"9202_CR246","doi-asserted-by":"publisher","first-page":"225re1","DOI":"10.1126\/scitranslmed.3008089","volume":"6","author":"J Guinea-Viniegra","year":"2014","unstructured":"Guinea-Viniegra J, Jim\u00e9nez M, Schonthaler HB et al (2014) Targeting miR-21 to treat psoriasis. Sci Transl Med 6:225re1. https:\/\/doi.org\/10.1126\/scitranslmed.3008089","journal-title":"Sci Transl Med"},{"key":"9202_CR247","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/j.1600-0625.2012.01462.x","volume":"21","author":"F Meisgen","year":"2012","unstructured":"Meisgen F, Xu N, Wei T et al (2012) MiR-21 is up-regulated in psoriasis and suppresses T cell apoptosis. Exp Dermatol 21:312\u2013314. https:\/\/doi.org\/10.1111\/j.1600-0625.2012.01462.x","journal-title":"Exp Dermatol"},{"key":"9202_CR248","doi-asserted-by":"publisher","first-page":"19640","DOI":"10.1002\/jcp.28564","volume":"234","author":"L-Y Chen","year":"2019","unstructured":"Chen L-Y, Wang X, Qu X-L et al (2019) Activation of the STAT3\/microRNA-21 pathway participates in angiotensin II-induced angiogenesis. J Cell Physiol 234:19640\u201319654. https:\/\/doi.org\/10.1002\/jcp.28564","journal-title":"J Cell Physiol"},{"key":"9202_CR249","doi-asserted-by":"publisher","first-page":"766757","DOI":"10.3389\/fimmu.2021.766757","volume":"12","author":"J Sun","year":"2021","unstructured":"Sun J, Liu R, He X et al (2021) MicroRNA-21 Regulates Diametrically Opposed Biological Functions of Regulatory T Cells. Front Immunol 12:766757. https:\/\/doi.org\/10.3389\/fimmu.2021.766757","journal-title":"Front Immunol"},{"key":"9202_CR250","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1074\/jbc.M116.769893","volume":"292","author":"A Torri","year":"2017","unstructured":"Torri A, Carpi D, Bulgheroni E et al (2017) Extracellular MicroRNA Signature of Human Helper T Cell Subsets in Health and Autoimmunity. J Biol Chem 292:2903\u20132915. https:\/\/doi.org\/10.1074\/jbc.M116.769893","journal-title":"J Biol Chem"},{"key":"9202_CR251","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1038\/s12276-021-00632-9","volume":"53","author":"G Choi","year":"2021","unstructured":"Choi G, Park Y-J, Cho M et al (2021) A critical role for Th17 cell-derived TGF-\u03b21 in regulating the stability and pathogenicity of autoimmune Th17 cells. Exp Mol Med 53:993\u20131004. https:\/\/doi.org\/10.1038\/s12276-021-00632-9","journal-title":"Exp Mol Med"},{"key":"9202_CR252","doi-asserted-by":"publisher","first-page":"qiae004","DOI":"10.1093\/jleuko\/qiae004","volume":"117","author":"M Zhang","year":"2024","unstructured":"Zhang M, Guan Y, Han M et al (2024) Foxo1 drives the TGF\u03b21-dependent dichotomy of Th17 cell fates. J Leukoc Biol 117:qiae004. https:\/\/doi.org\/10.1093\/jleuko\/qiae004","journal-title":"J Leukoc Biol"},{"key":"9202_CR253","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1038\/srep02038","volume":"3","author":"Q Li","year":"2013","unstructured":"Li Q, Zhang D, Wang Y et al (2013) MiR-21\/Smad 7 signaling determines TGF-\u03b21-induced CAF formation. Sci Rep 3:2038. https:\/\/doi.org\/10.1038\/srep02038","journal-title":"Sci Rep"},{"key":"9202_CR254","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.bbrc.2017.02.049","volume":"485","author":"H Wang","year":"2017","unstructured":"Wang H, Nie L, Wu L et al (2017) NR2F2 inhibits Smad7 expression and promotes TGF-\u03b2-dependent epithelial-mesenchymal transition of CRC via transactivation of miR-21. Biochem Biophys Res Commun 485:181\u2013188. https:\/\/doi.org\/10.1016\/j.bbrc.2017.02.049","journal-title":"Biochem Biophys Res Commun"},{"key":"9202_CR255","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.3389\/fimmu.2018.01407","volume":"9","author":"E Troncone","year":"2018","unstructured":"Troncone E, Marafini I, Stolfi C, Monteleone G (2018) Transforming Growth Factor-\u03b21\/Smad7 in Intestinal Immunity, Inflammation, and Cancer. Front Immunol 9:1407. https:\/\/doi.org\/10.3389\/fimmu.2018.01407","journal-title":"Front Immunol"},{"key":"9202_CR256","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3389\/fimmu.2015.00019","volume":"6","author":"FJ Sheedy","year":"2015","unstructured":"Sheedy FJ (2015) Turning 21: Induction of miR-21 as a Key Switch in the Inflammatory Response. Front Immunol 6:19. https:\/\/doi.org\/10.3389\/fimmu.2015.00019","journal-title":"Front Immunol"},{"key":"9202_CR257","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1172\/JCI74347","volume":"125","author":"G Murugaiyan","year":"2015","unstructured":"Murugaiyan G, da Cunha AP, Ajay AK et al (2015) MicroRNA-21 promotes Th17 differentiation and mediates experimental autoimmune encephalomyelitis. J Clin Invest 125:1069\u20131080. https:\/\/doi.org\/10.1172\/JCI74347","journal-title":"J Clin Invest"},{"key":"9202_CR258","doi-asserted-by":"publisher","first-page":"864","DOI":"10.3390\/ijms17060864","volume":"17","author":"S Wang","year":"2016","unstructured":"Wang S, Wan X, Ruan Q (2016) The MicroRNA-21 in Autoimmune Diseases. Int J Mol Sci 17:864. https:\/\/doi.org\/10.3390\/ijms17060864","journal-title":"Int J Mol Sci"},{"key":"9202_CR259","doi-asserted-by":"publisher","first-page":"6338","DOI":"10.1038\/s41598-021-85637-0","volume":"11","author":"S He","year":"2021","unstructured":"He S, Sun S, Lu J et al (2021) The effects of the miR-21\/SMAD7\/TGF-\u03b2 pathway on Th17 cell differentiation in COPD. Sci Rep 11:6338. https:\/\/doi.org\/10.1038\/s41598-021-85637-0","journal-title":"Sci Rep"},{"key":"9202_CR260","doi-asserted-by":"publisher","first-page":"30488","DOI":"10.1073\/pnas.2017056117","volume":"117","author":"C Wang","year":"2020","unstructured":"Wang C, Shen J, Ying J et al (2020) FoxO1 is a crucial mediator of TGF-\u03b2\/TAK1 signaling and protects against osteoarthritis by maintaining articular cartilage homeostasis. Proc Natl Acad Sci U S A 117:30488\u201330497. https:\/\/doi.org\/10.1073\/pnas.2017056117","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9202_CR261","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/imr.12735","volume":"288","author":"J Maul","year":"2019","unstructured":"Maul J, Alterauge D, Baumjohann D (2019) MicroRNA-mediated regulation of T follicular helper and T follicular regulatory cell identity. Immunol Rev 288:97\u2013111. https:\/\/doi.org\/10.1111\/imr.12735","journal-title":"Immunol Rev"},{"key":"9202_CR262","doi-asserted-by":"publisher","first-page":"646796","DOI":"10.3389\/fmed.2021.646796","volume":"8","author":"Y Xiuli","year":"2021","unstructured":"Xiuli Y, Honglin W (2021) miRNAs Flowing Up and Down: The Concerto of Psoriasis. Front Med (Lausanne) 8:646796. https:\/\/doi.org\/10.3389\/fmed.2021.646796","journal-title":"Front Med (Lausanne)"},{"key":"9202_CR263","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1172\/JCI97426","volume":"128","author":"R Wu","year":"2018","unstructured":"Wu R, Zeng J, Yuan J et al (2018) MicroRNA-210 overexpression promotes psoriasis-like inflammation by inducing Th1 and Th17 cell differentiation. J Clin Invest 128:2551\u20132568. https:\/\/doi.org\/10.1172\/JCI97426","journal-title":"J Clin Invest"},{"key":"9202_CR264","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.clim.2013.10.009","volume":"150","author":"M Zhao","year":"2014","unstructured":"Zhao M, Wang L, Liang G et al (2014) Up-regulation of microRNA-210 induces immune dysfunction via targeting FOXP3 in CD4(+) T cells of psoriasis vulgaris. Clin Immunol 150:22\u201330. https:\/\/doi.org\/10.1016\/j.clim.2013.10.009","journal-title":"Clin Immunol"},{"key":"9202_CR265","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1016\/j.biopha.2017.06.055","volume":"93","author":"X-Y Wang","year":"2017","unstructured":"Wang X-Y, Chen X-Y, Li J et al (2017) MiR-200a expression in CD4\u2009+\u2009T cells correlates with the expression of Th17\/Treg cells and relevant cytokines in psoriasis vulgaris: A case control study. Biomed Pharmacother 93:1158\u20131164. https:\/\/doi.org\/10.1016\/j.biopha.2017.06.055","journal-title":"Biomed Pharmacother"},{"key":"9202_CR266","doi-asserted-by":"publisher","first-page":"47872","DOI":"10.1021\/acsomega.4c08947","volume":"9","author":"M Mortoglou","year":"2024","unstructured":"Mortoglou M, Lian M, Miralles F et al (2024) miR-210 Mediated Hypoxic Responses in Pancreatic Ductal Adenocarcinoma. ACS Omega 9:47872\u201347883. https:\/\/doi.org\/10.1021\/acsomega.4c08947","journal-title":"ACS Omega"},{"key":"9202_CR267","doi-asserted-by":"publisher","first-page":"995","DOI":"10.3390\/biom15070995","volume":"15","author":"O Martinez-Arroyo","year":"2025","unstructured":"Martinez-Arroyo O, Flores-Chova A, Mendez-Debaets M et al (2025) Inhibiting miR-200a-3p Increases Sirtuin 1 and Mitigates Kidney Injury in a Tubular Cell Model of Diabetes and Hypertension-Related Renal Damage. Biomolecules 15:995. https:\/\/doi.org\/10.3390\/biom15070995","journal-title":"Biomolecules"},{"key":"9202_CR268","doi-asserted-by":"publisher","first-page":"205873842093374","DOI":"10.1177\/2058738420933742","volume":"34","author":"M El-Komy","year":"2020","unstructured":"El-Komy M, Amin I, El-Hawary MS et al (2020) Upregulation of the miRNA-155, miRNA-210, and miRNA-20b in psoriasis patients and their relation to IL-17. Int J Immunopathol Pharmacol 34:2058738420933742. https:\/\/doi.org\/10.1177\/2058738420933742","journal-title":"Int J Immunopathol Pharmacol"},{"key":"9202_CR269","doi-asserted-by":"publisher","first-page":"5599","DOI":"10.4049\/jimmunol.1303488","volume":"192","author":"E Zhu","year":"2014","unstructured":"Zhu E, Wang X, Zheng B et al (2014) miR-20b suppresses Th17 differentiation and the pathogenesis of experimental autoimmune encephalomyelitis by targeting ROR\u03b3t and STAT3. J Immunol 192:5599\u20135609. https:\/\/doi.org\/10.4049\/jimmunol.1303488","journal-title":"J Immunol"},{"key":"9202_CR270","doi-asserted-by":"publisher","first-page":"283","DOI":"10.5114\/ada.2020.96243","volume":"37","author":"B Nedoszytko","year":"2020","unstructured":"Nedoszytko B, Szczerkowska-Dobosz A, Stawczyk-Macieja M et al (2020) Pathogenesis of psoriasis in the omic era. Part II. Genetic, genomic and epigenetic changes in psoriasis. Postepy Dermatol Alergol 37:283\u2013298. https:\/\/doi.org\/10.5114\/ada.2020.96243","journal-title":"Postepy Dermatol Alergol"},{"key":"9202_CR271","doi-asserted-by":"publisher","first-page":"101573","DOI":"10.1016\/j.mcp.2020.101573","volume":"52","author":"D Zhang","year":"2020","unstructured":"Zhang D, Wang Y, Xia Y et al (2020) Repression of miR-142-3p alleviates psoriasis-like inflammation by repressing proliferation and promoting apoptosis of keratinocytes via targeting Sema3A. Mol Cell Probes 52:101573. https:\/\/doi.org\/10.1016\/j.mcp.2020.101573","journal-title":"Mol Cell Probes"},{"key":"9202_CR272","doi-asserted-by":"publisher","first-page":"6065","DOI":"10.1038\/s41598-018-24531-8","volume":"8","author":"SL Tung","year":"2018","unstructured":"Tung SL, Boardman DA, Sen M et al (2018) Regulatory T cell-derived extracellular vesicles modify dendritic cell function. Sci Rep 8:6065. https:\/\/doi.org\/10.1038\/s41598-018-24531-8","journal-title":"Sci Rep"},{"key":"9202_CR273","doi-asserted-by":"publisher","first-page":"649","DOI":"10.21037\/atm.2019.10.85","volume":"7","author":"N Ma","year":"2019","unstructured":"Ma N, Wei T, Wang B et al (2019) MicroRNA-142-3p inhibits IFN-\u03b3 production via targeting of RICTOR in Aspergillus fumigatus activated CD4\u2009+\u2009T cells. Ann Transl Med 7:649. https:\/\/doi.org\/10.21037\/atm.2019.10.85","journal-title":"Ann Transl Med"},{"key":"9202_CR274","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.jid.2022.12.013","volume":"143","author":"Q Meng","year":"2023","unstructured":"Meng Q, Bai M, Guo M et al (2023) Inhibition of Serum- and Glucocorticoid-Regulated Protein Kinase-1 Aggravates Imiquimod-Induced Psoriatic Dermatitis and Enhances Proinflammatory Cytokine Expression through the NF-kB Pathway. J Invest Dermatol 143:954\u2013964. https:\/\/doi.org\/10.1016\/j.jid.2022.12.013","journal-title":"J Invest Dermatol"},{"key":"9202_CR275","doi-asserted-by":"publisher","first-page":"e133721","DOI":"10.1172\/jci.insight.133721","volume":"5","author":"Y Meng","year":"2020","unstructured":"Meng Y, Li J, Ye Z et al (2020) MicroRNA-148a facilitates inflammatory dendritic cell differentiation and autoimmunity by targeting MAFB. JCI Insight 5:e133721. https:\/\/doi.org\/10.1172\/jci.insight.133721","journal-title":"JCI Insight"},{"key":"9202_CR276","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/eji.201343962","volume":"44","author":"EF Lind","year":"2014","unstructured":"Lind EF, Ohashi PS (2014) Mir-155, a central modulator of T-cell responses. Eur J Immunol 44:11\u201315. https:\/\/doi.org\/10.1002\/eji.201343962","journal-title":"Eur J Immunol"},{"key":"9202_CR277","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1073\/pnas.0610731104","volume":"104","author":"RM O\u2019Connell","year":"2007","unstructured":"O\u2019Connell RM, Taganov KD, Boldin MP et al (2007) MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci U S A 104:1604\u20131609. https:\/\/doi.org\/10.1073\/pnas.0610731104","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9202_CR278","first-page":"S56","volume":"34","author":"SY Na","year":"2016","unstructured":"Na SY, Park M-J, Park S, Lee E-S (2016) MicroRNA-155 regulates the Th17 immune response by targeting Ets-1 in Beh\u00e7et\u2019s disease. Clin Exp Rheumatol 34:S56\u2013S63","journal-title":"Clin Exp Rheumatol"},{"key":"9202_CR279","doi-asserted-by":"publisher","first-page":"1001201","DOI":"10.3389\/fimmu.2022.1001201","volume":"13","author":"Y Fang","year":"2022","unstructured":"Fang Y, Chen W, Li Z et al (2022) The role of a key transcription factor PU.1 in autoimmune diseases. Front Immunol 13:1001201. https:\/\/doi.org\/10.3389\/fimmu.2022.1001201","journal-title":"Front Immunol"},{"key":"9202_CR280","first-page":"120","volume":"18","author":"Z Jadali","year":"2019","unstructured":"Jadali Z (2019) Th9 Cells as a New Player in Inflammatory Skin Disorders. Iran J Allergy Asthma Immunol 18:120\u2013130","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"9202_CR281","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/s41598-018-19315-z","volume":"8","author":"TS Buttrick","year":"2018","unstructured":"Buttrick TS, Wang W, Yung C et al (2018) Foxo1 Promotes Th9 Cell Differentiation and Airway Allergy. Sci Rep 8:818. https:\/\/doi.org\/10.1038\/s41598-018-19315-z","journal-title":"Sci Rep"},{"key":"9202_CR282","doi-asserted-by":"publisher","first-page":"1650972","DOI":"10.3389\/fimmu.2025.1650972","volume":"16","author":"X Liu","year":"2025","unstructured":"Liu X, Li Y, Wu W et al (2025) Regulatory mechanisms of Th9 cell differentiation. Front Immunol 16:1650972. https:\/\/doi.org\/10.3389\/fimmu.2025.1650972","journal-title":"Front Immunol"},{"key":"9202_CR283","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.humimm.2021.07.002","volume":"82","author":"K Tian","year":"2021","unstructured":"Tian K, Xu W (2021) MiR-155 regulates Th9 differentiation in children with methicillin-resistant Staphylococcus aureus pneumonia by targeting SIRT1. Hum Immunol 82:775\u2013781. https:\/\/doi.org\/10.1016\/j.humimm.2021.07.002","journal-title":"Hum Immunol"},{"key":"9202_CR284","doi-asserted-by":"publisher","first-page":"146118","DOI":"10.1016\/j.gene.2021.146118","volume":"813","author":"L Li","year":"2022","unstructured":"Li L, Deng J, Huang T et al (2022) IRF4 transcriptionally activate HOTAIRM1, which in turn regulates IRF4 expression, thereby affecting Th9 cell differentiation and involved in allergic rhinitis. Gene 813:146118. https:\/\/doi.org\/10.1016\/j.gene.2021.146118","journal-title":"Gene"},{"key":"9202_CR285","doi-asserted-by":"publisher","first-page":"BSR20190986","DOI":"10.1042\/BSR20190986","volume":"39","author":"R Huang","year":"2019","unstructured":"Huang R, Chen X, Long Y, Chen R (2019) MiR-31 promotes Th22 differentiation through targeting Bach2 in coronary heart disease. Biosci Rep 39:BSR20190986. https:\/\/doi.org\/10.1042\/BSR20190986","journal-title":"Biosci Rep"},{"key":"9202_CR286","doi-asserted-by":"publisher","first-page":"678","DOI":"10.4049\/jimmunol.1202695","volume":"190","author":"N Xu","year":"2013","unstructured":"Xu N, Meisgen F, Butler LM et al (2013) MicroRNA-31 is overexpressed in psoriasis and modulates inflammatory cytokine and chemokine production in keratinocytes via targeting serine\/threonine kinase 40. J Immunol 190:678\u2013688. https:\/\/doi.org\/10.4049\/jimmunol.1202695","journal-title":"J Immunol"},{"key":"9202_CR287","doi-asserted-by":"publisher","first-page":"1608902","DOI":"10.3389\/fcell.2025.1608902","volume":"13","author":"S Li","year":"2025","unstructured":"Li S, Chik Z, Faruqu FN et al (2025) miRNAs and exosomes in psoriasis: coordinating cytoskeleton dynamics and extracellular matrix remodeling. Front Cell Dev Biol 13:1608902. https:\/\/doi.org\/10.3389\/fcell.2025.1608902","journal-title":"Front Cell Dev Biol"},{"key":"9202_CR288","doi-asserted-by":"publisher","first-page":"11467","DOI":"10.1038\/s41598-021-90972-3","volume":"11","author":"S Okumura","year":"2021","unstructured":"Okumura S, Hirano Y, Komatsu Y (2021) Stable duplex-linked antisense targeting miR-148a inhibits breast cancer cell proliferation. Sci Rep 11:11467. https:\/\/doi.org\/10.1038\/s41598-021-90972-3","journal-title":"Sci Rep"},{"key":"9202_CR289","doi-asserted-by":"publisher","first-page":"11498","DOI":"10.1038\/s41598-021-90944-7","volume":"11","author":"A Singh","year":"2021","unstructured":"Singh A, Dashynam M, Chim B et al (2021) Identification of Small Molecule Inhibitors of a Mir155 Transcriptional Reporter in Th17 Cells. Sci Rep 11:11498. https:\/\/doi.org\/10.1038\/s41598-021-90944-7","journal-title":"Sci Rep"},{"key":"9202_CR290","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/exd.13249","volume":"26","author":"Q Liu","year":"2017","unstructured":"Liu Q, Wu D-H, Han L et al (2017) Roles of microRNAs in psoriasis: Immunological functions and potential biomarkers. Exp Dermatol 26:359\u2013367. https:\/\/doi.org\/10.1111\/exd.13249","journal-title":"Exp Dermatol"},{"key":"9202_CR291","doi-asserted-by":"publisher","first-page":"104609","DOI":"10.1016\/j.drudis.2026.104609","volume":"31","author":"H Zhou","year":"2026","unstructured":"Zhou H, Lu J, Yin B et al (2026) Achieving durable psoriasis remission with nucleic acid therapeutics. Drug Discov Today 31:104609. https:\/\/doi.org\/10.1016\/j.drudis.2026.104609","journal-title":"Drug Discov Today"},{"key":"9202_CR292","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41580-022-00566-8","volume":"24","author":"JS Mattick","year":"2023","unstructured":"Mattick JS, Amaral PP, Carninci P et al (2023) Long non-coding RNAs: definitions, functions, challenges and recommendations. Nat Rev Mol Cell Biol 24:430\u2013447. https:\/\/doi.org\/10.1038\/s41580-022-00566-8","journal-title":"Nat Rev Mol Cell Biol"},{"key":"9202_CR293","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41573-021-00219-z","volume":"20","author":"M Winkle","year":"2021","unstructured":"Winkle M, El-Daly SM, Fabbri M, Calin GA (2021) Noncoding RNA therapeutics - challenges and potential solutions. Nat Rev Drug Discov 20:629\u2013651. https:\/\/doi.org\/10.1038\/s41573-021-00219-z","journal-title":"Nat Rev Drug Discov"},{"key":"9202_CR294","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.2147\/IJN.S441353","volume":"19","author":"Y Han","year":"2024","unstructured":"Han Y, Xi L, Leng F et al (2024) Topical Delivery of microRNA-125b by Framework Nucleic Acids for Psoriasis Treatment. Int J Nanomed 19:2625\u20132638. https:\/\/doi.org\/10.2147\/IJN.S441353","journal-title":"Int J Nanomed"},{"key":"9202_CR295","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.imlet.2015.05.014","volume":"166","author":"D Fu","year":"2015","unstructured":"Fu D, Yu W, Li M et al (2015) MicroRNA-138 regulates the balance of Th1\/Th2 via targeting RUNX3 in psoriasis. Immunol Lett 166:55\u201362. https:\/\/doi.org\/10.1016\/j.imlet.2015.05.014","journal-title":"Immunol Lett"},{"key":"9202_CR296","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.cell.2010.08.012","volume":"142","author":"L-F Lu","year":"2010","unstructured":"Lu L-F, Boldin MP, Chaudhry A et al (2010) Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses. Cell 142:914\u2013929. https:\/\/doi.org\/10.1016\/j.cell.2010.08.012","journal-title":"Cell"},{"key":"9202_CR297","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s40291-024-00714-0","volume":"28","author":"P-Y Ho","year":"2024","unstructured":"Ho P-Y, Huang Y-C (2024) MicroRNA-146a Signature in Psoriasis: A Systematic Review and Meta-Analysis. Mol Diagn Ther 28:379\u2013388. https:\/\/doi.org\/10.1007\/s40291-024-00714-0","journal-title":"Mol Diagn Ther"},{"key":"9202_CR298","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/cmi.2011.27","volume":"8","author":"L Zhou","year":"2011","unstructured":"Zhou L, Park J-J, Zheng Q et al (2011) MicroRNAs are key regulators controlling iNKT and regulatory T-cell development and function. Cell Mol Immunol 8:380\u2013387. https:\/\/doi.org\/10.1038\/cmi.2011.27","journal-title":"Cell Mol Immunol"},{"key":"9202_CR299","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1111\/exd.12469","volume":"23","author":"A Pivarcsi","year":"2014","unstructured":"Pivarcsi A, St\u00e5hle M, Sonkoly E (2014) Genetic polymorphisms altering microRNA activity in psoriasis\u2013a key to solve the puzzle of missing heritability? Exp Dermatol 23:620\u2013624. https:\/\/doi.org\/10.1111\/exd.12469","journal-title":"Exp Dermatol"},{"key":"9202_CR300","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.jaci.2016.07.025","volume":"139","author":"A Srivastava","year":"2017","unstructured":"Srivastava A, Nikamo P, Lohcharoenkal W et al (2017) MicroRNA-146a suppresses IL-17-mediated skin inflammation and is genetically associated with psoriasis. J Allergy Clin Immunol 139:550\u2013561. https:\/\/doi.org\/10.1016\/j.jaci.2016.07.025","journal-title":"J Allergy Clin Immunol"},{"key":"9202_CR301","doi-asserted-by":"publisher","DOI":"10.1007\/s13410-026-01652-9","author":"L Venuh","year":"2026","unstructured":"Venuh L, Kaur P (2026) Genetic crosstalk at the non-coding frontier: miRNA SNPs connecting diabetes and psoriasis. Int J Diabetes Dev Ctries. https:\/\/doi.org\/10.1007\/s13410-026-01652-9","journal-title":"Int J Diabetes Dev Ctries"},{"key":"9202_CR302","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1111\/jcmm.12359","volume":"18","author":"W Zhang","year":"2014","unstructured":"Zhang W, Yi X, Guo S et al (2014) A single-nucleotide polymorphism of miR-146a and psoriasis: an association and functional study. J Cell Mol Med 18:2225\u20132234. https:\/\/doi.org\/10.1111\/jcmm.12359","journal-title":"J Cell Mol Med"},{"key":"9202_CR303","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s12519-019-00265-z","volume":"16","author":"Z-D Fan","year":"2020","unstructured":"Fan Z-D, Cao Q, Huang N et al (2020) MicroRNA-125b regulates Th17\/Treg cell differentiation and is associated with juvenile idiopathic arthritis. World J Pediatr 16:99\u2013110. https:\/\/doi.org\/10.1007\/s12519-019-00265-z","journal-title":"World J Pediatr"},{"key":"9202_CR304","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/j.omtn.2021.07.010","volume":"26","author":"Y Gu","year":"2021","unstructured":"Gu Y, Zhou H, Yu H et al (2021) miR-99a regulates CD4\u2009+\u2009T cell differentiation and attenuates experimental autoimmune encephalomyelitis by mTOR-mediated glycolysis. Mol Ther Nucleic Acids 26:1173\u20131185. https:\/\/doi.org\/10.1016\/j.omtn.2021.07.010","journal-title":"Mol Ther Nucleic Acids"},{"key":"9202_CR305","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.immuni.2014.12.030","volume":"42","author":"J Blagih","year":"2015","unstructured":"Blagih J, Coulombe F, Vincent EE et al (2015) The energy sensor AMPK regulates T cell metabolic adaptation and effector responses in vivo. Immunity 42:41\u201354. https:\/\/doi.org\/10.1016\/j.immuni.2014.12.030","journal-title":"Immunity"},{"key":"9202_CR306","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/nyas.12059","volume":"1280","author":"S Nagai","year":"2013","unstructured":"Nagai S, Kurebayashi Y, Koyasu S (2013) Role of PI3K\/Akt and mTOR complexes in Th17 cell differentiation. Ann N Y Acad Sci 1280:30\u201334. https:\/\/doi.org\/10.1111\/nyas.12059","journal-title":"Ann N Y Acad Sci"},{"key":"9202_CR307","doi-asserted-by":"publisher","first-page":"1782712","DOI":"10.3389\/fcimb.2026.1782712","volume":"16","author":"G Sheng","year":"2026","unstructured":"Sheng G, Li C, Liu D et al (2026) The role and significance of the PI3K\/Akt-mTOR signaling pathway in infectious diseases. Front Cell Infect Microbiol 16:1782712. https:\/\/doi.org\/10.3389\/fcimb.2026.1782712","journal-title":"Front Cell Infect Microbiol"},{"key":"9202_CR308","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.immuni.2021.04.008","volume":"54","author":"K Xu","year":"2021","unstructured":"Xu K, Yin N, Peng M et al (2021) Glycolytic ATP fuels phosphoinositide 3-kinase signaling to support effector T helper 17 cell responses. Immunity 54:976\u2013987e7. https:\/\/doi.org\/10.1016\/j.immuni.2021.04.008","journal-title":"Immunity"},{"key":"9202_CR309","doi-asserted-by":"publisher","first-page":"117123","DOI":"10.1016\/j.celrep.2026.117123","volume":"45","author":"P Dong","year":"2026","unstructured":"Dong P, Liu L, Yu J et al (2026) Enhanced HIF-1\u03b1 cooperation by a human ROR\u03b3t mutant potentiates Th17 pathogenicity. Cell Rep 45:117123. https:\/\/doi.org\/10.1016\/j.celrep.2026.117123","journal-title":"Cell Rep"},{"key":"9202_CR310","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1038\/s12276-025-01535-9","volume":"57","author":"E Park","year":"2025","unstructured":"Park E, Ciofani M (2025) Th17 cell pathogenicity in autoimmune disease. Exp Mol Med 57:1913\u20131927. https:\/\/doi.org\/10.1038\/s12276-025-01535-9","journal-title":"Exp Mol Med"},{"key":"9202_CR311","doi-asserted-by":"publisher","first-page":"103738","DOI":"10.1016\/j.autrev.2024.103738","volume":"24","author":"Y Chen","year":"2025","unstructured":"Chen Y, Lin Q, Cheng H et al (2025) Immunometabolic shifts in autoimmune disease: Mechanisms and pathophysiological implications. Autoimmun Rev 24:103738. https:\/\/doi.org\/10.1016\/j.autrev.2024.103738","journal-title":"Autoimmun Rev"},{"key":"9202_CR312","doi-asserted-by":"publisher","first-page":"711060","DOI":"10.3389\/fimmu.2021.711060","volume":"12","author":"Y Hao","year":"2021","unstructured":"Hao Y, Zhu Y-J, Zou S et al (2021) Metabolic Syndrome and Psoriasis: Mechanisms and Future Directions. Front Immunol 12:711060. https:\/\/doi.org\/10.3389\/fimmu.2021.711060","journal-title":"Front Immunol"},{"key":"9202_CR313","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41392-024-01954-6","volume":"9","author":"T Hu","year":"2024","unstructured":"Hu T, Liu C-H, Lei M et al (2024) Metabolic regulation of the immune system in health and diseases: mechanisms and interventions. Signal Transduct Target Ther 9:268. https:\/\/doi.org\/10.1038\/s41392-024-01954-6","journal-title":"Signal Transduct Target Ther"},{"key":"9202_CR314","doi-asserted-by":"publisher","first-page":"3232061","DOI":"10.1155\/2020\/3232061","volume":"2020","author":"C Liu","year":"2020","unstructured":"Liu C, Li N, Liu G (2020) The Role of MicroRNAs in Regulatory T Cells. J Immunol Res 2020:3232061. https:\/\/doi.org\/10.1155\/2020\/3232061","journal-title":"J Immunol Res"},{"key":"9202_CR315","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1111\/all.15163","volume":"77","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Yang Y, Guo J et al (2022) miR-146a enhances regulatory T-cell differentiation and function in allergic rhinitis by targeting STAT5b. Allergy 77:550\u2013558. https:\/\/doi.org\/10.1111\/all.15163","journal-title":"Allergy"},{"key":"9202_CR316","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/s41420-021-00534-9","volume":"7","author":"J Lu","year":"2021","unstructured":"Lu J, Wang W, Li P et al (2021) MiR-146a regulates regulatory T cells to suppress heart transplant rejection in mice. Cell Death Discov 7:165. https:\/\/doi.org\/10.1038\/s41420-021-00534-9","journal-title":"Cell Death Discov"},{"key":"9202_CR317","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1002\/eji.202149315","volume":"51","author":"M De Simone","year":"2021","unstructured":"De Simone M, Chirichella M, Emming S et al (2021) Ex vivo microRNA and gene expression profiling of human Tr1-like cells suggests a role for miR-92a and \u2013\u2009125a in the regulation of EOMES and IL-10R. Eur J Immunol 51:3243\u20133246. https:\/\/doi.org\/10.1002\/eji.202149315","journal-title":"Eur J Immunol"},{"key":"9202_CR318","doi-asserted-by":"publisher","first-page":"103784","DOI":"10.1016\/j.autrev.2025.103784","volume":"24","author":"G Bagni","year":"2025","unstructured":"Bagni G, Biancalana E, Chiara E et al (2025) Epigenetics in autoimmune diseases: Unraveling the hidden regulators of immune dysregulation. Autoimmun Rev 24:103784. https:\/\/doi.org\/10.1016\/j.autrev.2025.103784","journal-title":"Autoimmun Rev"},{"key":"9202_CR319","doi-asserted-by":"publisher","first-page":"790722","DOI":"10.3389\/fcell.2021.790722","volume":"9","author":"K Nazimek","year":"2021","unstructured":"Nazimek K, Bryniarski K (2021) Increasing the Therapeutic Efficacy of Extracellular Vesicles From the Antigen-Specific Antibody and Light Chain Perspective. Front Cell Dev Biol 9:790722. https:\/\/doi.org\/10.3389\/fcell.2021.790722","journal-title":"Front Cell Dev Biol"},{"key":"9202_CR320","doi-asserted-by":"publisher","first-page":"e14221","DOI":"10.1111\/dth.14221","volume":"33","author":"S Pradyuth","year":"2020","unstructured":"Pradyuth S, Rapalli VK, Gorantla S et al (2020) Insightful exploring of microRNAs in psoriasis and its targeted topical delivery. Dermatol Ther 33:e14221. https:\/\/doi.org\/10.1111\/dth.14221","journal-title":"Dermatol Ther"},{"key":"9202_CR321","doi-asserted-by":"publisher","first-page":"124435","DOI":"10.1016\/j.ijpharm.2024.124435","volume":"661","author":"G Subramanian","year":"2024","unstructured":"Subramanian G, Kalidasan K, Quah S et al (2024) Breaking barriers: Innovative approaches for skin delivery of RNA therapeutics. Int J Pharm 661:124435. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.124435","journal-title":"Int J Pharm"},{"key":"9202_CR322","doi-asserted-by":"publisher","first-page":"113664","DOI":"10.1016\/j.jconrel.2025.113664","volume":"382","author":"J Yang","year":"2025","unstructured":"Yang J, Zhu J, Lu S et al (2025) Transdermal psoriasis treatment inspired by tumor microenvironment-mediated immunomodulation and advanced by exosomal engineering. J Control Release 382:113664. https:\/\/doi.org\/10.1016\/j.jconrel.2025.113664","journal-title":"J Control Release"},{"key":"9202_CR323","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.4049\/jimmunol.1800189","volume":"201","author":"J Bian","year":"2018","unstructured":"Bian J, Liu R, Fan T et al (2018) miR-340 Alleviates Psoriasis in Mice through Direct Targeting of IL-17A. J Immunol 201:1412\u20131420. https:\/\/doi.org\/10.4049\/jimmunol.1800189","journal-title":"J Immunol"},{"key":"9202_CR324","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3389\/fimmu.2019.00015","volume":"10","author":"V Salvi","year":"2019","unstructured":"Salvi V, Gianello V, Tiberio L et al (2019) Cytokine Targeting by miRNAs in Autoimmune Diseases. Front Immunol 10:15. https:\/\/doi.org\/10.3389\/fimmu.2019.00015","journal-title":"Front Immunol"},{"key":"9202_CR325","doi-asserted-by":"publisher","first-page":"18658","DOI":"10.1021\/acsami.5c25947","volume":"18","author":"Y Li","year":"2026","unstructured":"Li Y, Liu S, Yang J et al (2026) Rational Design of Spherical Nucleic Acids: Expanding Horizons for Precision Nucleic Acid Therapy. ACS Appl Mater Interfaces 18:18658\u201318681. https:\/\/doi.org\/10.1021\/acsami.5c25947","journal-title":"ACS Appl Mater Interfaces"},{"key":"9202_CR326","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1007\/s00210-024-03528-3","volume":"398","author":"OA Mohammed","year":"2025","unstructured":"Mohammed OA, Alghamdi M, Bahashwan E et al (2025) Emerging insights into the role of natural products and miRNAs in psoriasis: from pathophysiology to precision medicine. Naunyn Schmiedebergs Arch Pharmacol 398:2487\u20132509. https:\/\/doi.org\/10.1007\/s00210-024-03528-3","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"9202_CR327","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.jaci.2013.04.048","volume":"132","author":"K Bryniarski","year":"2013","unstructured":"Bryniarski K, Ptak W, Jayakumar A et al (2013) Antigen-specific, antibody-coated, exosome-like nanovesicles deliver suppressor T-cell microRNA-150 to effector T cells to inhibit contact sensitivity. J Allergy Clin Immunol 132:170\u2013181. https:\/\/doi.org\/10.1016\/j.jaci.2013.04.048","journal-title":"J Allergy Clin Immunol"},{"key":"9202_CR328","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00005-015-0331-4","volume":"63","author":"W Ptak","year":"2015","unstructured":"Ptak W, Nazimek K, Askenase PW, Bryniarski K (2015) From Mysterious Supernatant Entity to miRNA-150 in Antigen-Specific Exosomes: a History of Hapten-Specific T Suppressor Factor. Arch Immunol Ther Exp (Warsz) 63:345\u2013356. https:\/\/doi.org\/10.1007\/s00005-015-0331-4","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"9202_CR329","doi-asserted-by":"publisher","first-page":"907","DOI":"10.3390\/nu11040907","volume":"11","author":"M W\u0105sik","year":"2019","unstructured":"W\u0105sik M, Nazimek K, Nowak B et al (2019) Delayed-Type Hypersensitivity Underlying Casein Allergy Is Suppressed by Extracellular Vesicles Carrying miRNA-150. Nutrients 11:907. https:\/\/doi.org\/10.3390\/nu11040907","journal-title":"Nutrients"},{"key":"9202_CR330","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.3390\/ijms19092656","volume":"19","author":"K Nazimek","year":"2018","unstructured":"Nazimek K, Askenase PW, Bryniarski K (2018) Antibody Light Chains Dictate the Specificity of Contact Hypersensitivity Effector Cell Suppression Mediated by Exosomes. Int J Mol Sci 19:2656. https:\/\/doi.org\/10.3390\/ijms19092656","journal-title":"Int J Mol Sci"},{"key":"9202_CR331","doi-asserted-by":"publisher","first-page":"5540","DOI":"10.3390\/ijms21155540","volume":"21","author":"K Nazimek","year":"2020","unstructured":"Nazimek K, Bryniarski K, Ptak W et al (2020) Orally Administered Exosomes Suppress Mouse Delayed-Type Hypersensitivity by Delivering miRNA-150 to Antigen-Primed Macrophage APC Targeted by Exosome-Surface Anti-Peptide Antibody Light Chains. Int J Mol Sci 21:5540. https:\/\/doi.org\/10.3390\/ijms21155540","journal-title":"Int J Mol Sci"},{"key":"9202_CR332","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/imm.12466","volume":"146","author":"K Nazimek","year":"2015","unstructured":"Nazimek K, Ptak W, Nowak B et al (2015) Macrophages play an essential role in antigen-specific immune suppression mediated by T CD8+ cell-derived exosomes. Immunology 146:23\u201332. https:\/\/doi.org\/10.1111\/imm.12466","journal-title":"Immunology"},{"key":"9202_CR333","doi-asserted-by":"publisher","first-page":"734","DOI":"10.3390\/ph14080734","volume":"14","author":"K Nazimek","year":"2021","unstructured":"Nazimek K, Bustos-Mor\u00e1n E, Blas-Rus N et al (2021) Antibodies Enhance the Suppressive Activity of Extracellular Vesicles in Mouse Delayed-Type Hypersensitivity. Pharmaceuticals (Basel) 14:734. https:\/\/doi.org\/10.3390\/ph14080734","journal-title":"Pharmaceuticals (Basel)"},{"key":"9202_CR334","doi-asserted-by":"publisher","first-page":"e12881","DOI":"10.1111\/sji.12881","volume":"91","author":"K Nazimek","year":"2020","unstructured":"Nazimek K, Bryniarski K (2020) Approaches to inducing antigen-specific immune tolerance in allergy and autoimmunity: Focus on antigen-presenting cells and extracellular vesicles. Scand J Immunol 91:e12881. https:\/\/doi.org\/10.1111\/sji.12881","journal-title":"Scand J Immunol"},{"key":"9202_CR335","doi-asserted-by":"publisher","first-page":"e0122991","DOI":"10.1371\/journal.pone.0122991","volume":"10","author":"K Bryniarski","year":"2015","unstructured":"Bryniarski K, Ptak W, Martin E et al (2015) Free Extracellular miRNA Functionally Targets Cells by Transfecting Exosomes from Their Companion Cells. PLoS ONE 10:e0122991. https:\/\/doi.org\/10.1371\/journal.pone.0122991","journal-title":"PLoS ONE"},{"key":"9202_CR336","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cellimm.2016.05.007","volume":"306\u2013307","author":"W Sang","year":"2016","unstructured":"Sang W, Sun C, Zhang C et al (2016) MicroRNA-150 negatively regulates the function of CD4(+) T cells through AKT3\/Bim signaling pathway. Cell Immunol 306\u2013307:35\u201340. https:\/\/doi.org\/10.1016\/j.cellimm.2016.05.007","journal-title":"Cell Immunol"},{"key":"9202_CR337","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1111\/cea.13475","volume":"49","author":"K Nazimek","year":"2019","unstructured":"Nazimek K, Bustos-Mor\u00e1n E, Blas-Rus N et al (2019) Syngeneic red blood cell-induced extracellular vesicles suppress delayed-type hypersensitivity to self-antigens in mice. Clin Exp Allergy 49:1487\u20131499. https:\/\/doi.org\/10.1111\/cea.13475","journal-title":"Clin Exp Allergy"},{"key":"9202_CR338","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/ni1500","volume":"8","author":"A Br\u00fcstle","year":"2007","unstructured":"Br\u00fcstle A, Heink S, Huber M et al (2007) The development of inflammatory T(H)-17 cells requires interferon-regulatory factor 4. Nat Immunol 8:958\u2013966. https:\/\/doi.org\/10.1038\/ni1500","journal-title":"Nat Immunol"},{"key":"9202_CR339","doi-asserted-by":"publisher","first-page":"3290","DOI":"10.1182\/blood-2011-02-336552","volume":"118","author":"R Noubade","year":"2011","unstructured":"Noubade R, Krementsov DN, Del Rio R et al (2011) Activation of p38 MAPK in CD4 T cells controls IL-17 production and autoimmune encephalomyelitis. Blood 118:3290\u20133300. https:\/\/doi.org\/10.1182\/blood-2011-02-336552","journal-title":"Blood"},{"key":"9202_CR340","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/s1074-7613(00)80640-8","volume":"9","author":"DD Yang","year":"1998","unstructured":"Yang DD, Conze D, Whitmarsh AJ et al (1998) Differentiation of CD4\u2009+\u2009T cells to Th1 cells requires MAP kinase JNK2. Immunity 9:575\u2013585. https:\/\/doi.org\/10.1016\/s1074-7613(00)80640-8","journal-title":"Immunity"},{"key":"9202_CR341","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.15252\/embj.201489589","volume":"34","author":"SC Warth","year":"2015","unstructured":"Warth SC, Hoefig KP, Hiekel A et al (2015) Induced miR-99a expression represses Mtor cooperatively with miR-150 to promote regulatory T-cell differentiation. EMBO J 34:1195\u20131213. https:\/\/doi.org\/10.15252\/embj.201489589","journal-title":"EMBO J"},{"key":"9202_CR342","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.gastha.2023.01.021","volume":"2","author":"S Ishihara","year":"2023","unstructured":"Ishihara S, Sato M, Miyazaki H et al (2023) Deletion of miR-150 Prevents Spontaneous T Cell Proliferation and the Development of Colitis. Gastro Hep Adv 2:487\u2013496. https:\/\/doi.org\/10.1016\/j.gastha.2023.01.021","journal-title":"Gastro Hep Adv"},{"key":"9202_CR343","doi-asserted-by":"publisher","first-page":"e3000646","DOI":"10.1371\/journal.pbio.3000646","volume":"18","author":"C \u00c1lvarez-Salamero","year":"2020","unstructured":"\u00c1lvarez-Salamero C, Castillo-Gonz\u00e1lez R, Pastor-Fern\u00e1ndez G et al (2020) IL-23 signaling regulation of pro-inflammatory T-cell migration uncovered by phosphoproteomics. PLoS Biol 18:e3000646. https:\/\/doi.org\/10.1371\/journal.pbio.3000646","journal-title":"PLoS Biol"},{"key":"9202_CR344","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.neo.2015.04.005","volume":"17","author":"R Moles","year":"2015","unstructured":"Moles R, Bellon M, Nicot C (2015) STAT1: A Novel Target of miR-150 and miR-223 Is Involved in the Proliferation of HTLV-I-Transformed and ATL Cells. Neoplasia 17:449\u2013462. https:\/\/doi.org\/10.1016\/j.neo.2015.04.005","journal-title":"Neoplasia"},{"key":"9202_CR345","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1515\/biol-2020-0058","volume":"15","author":"X Deng","year":"2020","unstructured":"Deng X, Lin Z, Zuo C, Fu Y (2020) Upregulation of miR-150-5p alleviates LPS-induced inflammatory response and apoptosis of RAW264.7 macrophages by targeting Notch1. Open Life Sci 15:544\u2013552. https:\/\/doi.org\/10.1515\/biol-2020-0058","journal-title":"Open Life Sci"},{"key":"9202_CR346","doi-asserted-by":"publisher","unstructured":"Ma L, Xue H, Gao T et al (2018) Notch1 Signaling Regulates the Th17\/Treg Immune Imbalance in Patients with Psoriasis Vulgaris. Mediators Inflamm 2018:3069521. https:\/\/doi.org\/10.1155\/2018\/3069521","DOI":"10.1155\/2018\/3069521"},{"key":"9202_CR347","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1016\/j.jaci.2017.07.019","volume":"141","author":"S-H Seo","year":"2018","unstructured":"Seo S-H, Jang MS, Kim D-J et al (2018) MicroRNA-150 controls differentiation of intraepithelial lymphocytes through TGF-\u03b2 receptor II regulation. J Allergy Clin Immunol 141:1382\u20131394e14. https:\/\/doi.org\/10.1016\/j.jaci.2017.07.019","journal-title":"J Allergy Clin Immunol"},{"key":"9202_CR348","doi-asserted-by":"publisher","first-page":"3334","DOI":"10.1038\/s41467-020-17097-5","volume":"11","author":"H Xu","year":"2020","unstructured":"Xu H, Agalioti T, Zhao J et al (2020) The induction and function of the anti-inflammatory fate of TH17 cells. Nat Commun 11:3334. https:\/\/doi.org\/10.1038\/s41467-020-17097-5","journal-title":"Nat Commun"},{"key":"9202_CR349","doi-asserted-by":"publisher","first-page":"25602","DOI":"10.1038\/srep25602","volume":"6","author":"Z Wang","year":"2016","unstructured":"Wang Z, Xu L, Hu Y et al (2016) miRNA let-7b modulates macrophage polarization and enhances tumor-associated macrophages to promote angiogenesis and mobility in prostate cancer. Sci Rep 6:25602. https:\/\/doi.org\/10.1038\/srep25602","journal-title":"Sci Rep"},{"key":"9202_CR350","doi-asserted-by":"publisher","first-page":"7598","DOI":"10.3390\/ijms26157598","volume":"26","author":"A Fedor","year":"2025","unstructured":"Fedor A, Bryniarski K, Nazimek K (2025) mTOR Signaling in Macrophages: All Depends on the Context. Int J Mol Sci 26:7598. https:\/\/doi.org\/10.3390\/ijms26157598","journal-title":"Int J Mol Sci"},{"key":"9202_CR351","doi-asserted-by":"publisher","first-page":"6778","DOI":"10.3390\/ijms25126778","volume":"25","author":"K Joo","year":"2024","unstructured":"Joo K, Karsulovic C, Sore M, Hojman L (2024) Pivotal Role of mTOR in Non-Skin Manifestations of Psoriasis. Int J Mol Sci 25:6778. https:\/\/doi.org\/10.3390\/ijms25126778","journal-title":"Int J Mol Sci"},{"key":"9202_CR352","doi-asserted-by":"publisher","first-page":"4334","DOI":"10.1172\/JCI81676","volume":"125","author":"M Ouimet","year":"2015","unstructured":"Ouimet M, Ediriweera HN, Gundra UM et al (2015) MicroRNA-33-dependent regulation of macrophage metabolism directs immune cell polarization in atherosclerosis. J Clin Invest 125:4334\u20134348. https:\/\/doi.org\/10.1172\/JCI81676","journal-title":"J Clin Invest"},{"key":"9202_CR353","doi-asserted-by":"publisher","first-page":"17057","DOI":"10.1039\/c9ra01374a","volume":"9","author":"J Huang","year":"2019","unstructured":"Huang J, Fu X, Chen X et al (2019) Silencing of miR-486 alleviates LPS-stimulated inflammatory response of macrophages through targeting SIRT1. RSC Adv 9:17057\u201317064. https:\/\/doi.org\/10.1039\/c9ra01374a","journal-title":"RSC Adv"},{"key":"9202_CR354","doi-asserted-by":"publisher","first-page":"830420","DOI":"10.3389\/fonc.2022.830420","volume":"12","author":"Y-Z Jia","year":"2022","unstructured":"Jia Y-Z, Liu J, Wang G-Q, Song Z-F (2022) miR-484: A Potential Biomarker in Health and Disease. Front Oncol 12:830420. https:\/\/doi.org\/10.3389\/fonc.2022.830420","journal-title":"Front Oncol"},{"key":"9202_CR355","doi-asserted-by":"publisher","first-page":"120633","DOI":"10.1016\/j.cca.2025.120633","volume":"579","author":"S Singh","year":"2026","unstructured":"Singh S, Rajappa M (2026) MicroRNA biomarkers in psoriasis. Clin Chim Acta 579:120633. https:\/\/doi.org\/10.1016\/j.cca.2025.120633","journal-title":"Clin Chim Acta"},{"key":"9202_CR356","doi-asserted-by":"publisher","first-page":"7437281","DOI":"10.1155\/2022\/7437281","volume":"2022","author":"J Hu","year":"2022","unstructured":"Hu J, Huang S, Liu X et al (2022) miR-155: An Important Role in Inflammation Response. J Immunol Res 2022:7437281. https:\/\/doi.org\/10.1155\/2022\/7437281","journal-title":"J Immunol Res"},{"key":"9202_CR357","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.imlet.2020.07.008","volume":"227","author":"SS Mortazavi-Jahromi","year":"2020","unstructured":"Mortazavi-Jahromi SS, Aslani M, Mirshafiey A (2020) A comprehensive review on miR-146a molecular mechanisms in a wide spectrum of immune and non-immune inflammatory diseases. Immunol Lett 227:8\u201327. https:\/\/doi.org\/10.1016\/j.imlet.2020.07.008","journal-title":"Immunol Lett"},{"key":"9202_CR358","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s13555-024-01331-9","volume":"15","author":"F Diotallevi","year":"2025","unstructured":"Diotallevi F, Matacchione G, Campanati A et al (2025) Circulating MicroRNAs in Patients with Psoriasis Treated with Anti-IL-23: A Cohort Study. Dermatol Ther (Heidelb) 15:125\u2013140. https:\/\/doi.org\/10.1007\/s13555-024-01331-9","journal-title":"Dermatol Ther (Heidelb)"},{"key":"9202_CR359","doi-asserted-by":"publisher","first-page":"7221","DOI":"10.3390\/ijms27167221","volume":"27","author":"JA Lewandowska","year":"2026","unstructured":"Lewandowska JA, Owczarczyk-Saczonek A, Nedoszytko B (2026) Inflammatory Biomarkers for Assessing Treatment Response in Psoriasis: A Narrative Review. Int J Mol Sci 27:7221. https:\/\/doi.org\/10.3390\/ijms27167221","journal-title":"Int J Mol Sci"},{"key":"9202_CR360","doi-asserted-by":"publisher","first-page":"e1198","DOI":"10.1097\/PR9.0000000000001198","volume":"9","author":"JT DaCunza","year":"2024","unstructured":"DaCunza JT, Wickman JR, Ajit SK (2024) miRNA packaging into small extracellular vesicles and implications in pain. Pain Rep 9:e1198. https:\/\/doi.org\/10.1097\/PR9.0000000000001198","journal-title":"Pain Rep"},{"key":"9202_CR361","doi-asserted-by":"publisher","first-page":"102206","DOI":"10.1016\/j.labinv.2024.102206","volume":"105","author":"X-M Liu","year":"2025","unstructured":"Liu X-M, Halushka MK (2025) Beyond the Bubble: A Debate on microRNA Sorting Into Extracellular Vesicles. Lab Invest 105:102206. https:\/\/doi.org\/10.1016\/j.labinv.2024.102206","journal-title":"Lab Invest"},{"key":"9202_CR362","doi-asserted-by":"publisher","first-page":"4623","DOI":"10.3390\/ijms21134623","volume":"21","author":"K Nazimek","year":"2020","unstructured":"Nazimek K, Bryniarski K (2020) Perspectives in Manipulating EVs for Therapeutic Applications: Focus on Cancer Treatment. Int J Mol Sci 21:4623. https:\/\/doi.org\/10.3390\/ijms21134623","journal-title":"Int J Mol Sci"},{"key":"9202_CR363","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/j.omtn.2021.11.007","volume":"26","author":"S Sakshi","year":"2021","unstructured":"Sakshi S, Jayasuriya R, Ganesan K et al (2021) Role of circRNA-miRNA-mRNA interaction network in diabetes and its associated complications. Mol Ther Nucleic Acids 26:1291\u20131302. https:\/\/doi.org\/10.1016\/j.omtn.2021.11.007","journal-title":"Mol Ther Nucleic Acids"},{"key":"9202_CR364","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1007\/s11033-025-10906-4","volume":"52","author":"M Singh","year":"2025","unstructured":"Singh M, Priya K, Nagar A, Nalavade R (2025) Emerging landscape of lncRNA-miRNA interactions as architects of gene expression patterns. Mol Biol Rep 52:810. https:\/\/doi.org\/10.1007\/s11033-025-10906-4","journal-title":"Mol Biol Rep"},{"key":"9202_CR365","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1021\/acs.chemrev.3c00611","volume":"124","author":"Y Shi","year":"2024","unstructured":"Shi Y, Zhen X, Zhang Y et al (2024) Chemically Modified Platforms for Better RNA Therapeutics. Chem Rev 124:929\u20131033. https:\/\/doi.org\/10.1021\/acs.chemrev.3c00611","journal-title":"Chem Rev"},{"key":"9202_CR366","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.3390\/ijms25031469","volume":"25","author":"AA Seyhan","year":"2024","unstructured":"Seyhan AA (2024) Trials and Tribulations of MicroRNA Therapeutics. Int J Mol Sci 25:1469. https:\/\/doi.org\/10.3390\/ijms25031469","journal-title":"Int J Mol Sci"},{"key":"9202_CR367","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.3390\/ijms27052162","volume":"27","author":"H V\u00e9lez-Slimani","year":"2026","unstructured":"V\u00e9lez-Slimani H, Salazar LA (2026) Therapeutic microRNAs: Mechanisms, Delivery, and Clinical Translation in Oncology. Int J Mol Sci 27:2162. https:\/\/doi.org\/10.3390\/ijms27052162","journal-title":"Int J Mol Sci"},{"key":"9202_CR368","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s00253-025-13620-0","volume":"109","author":"Z Wang","year":"2025","unstructured":"Wang Z, Peng Y, Zhou H et al (2025) MiRNA-based drugs: challenges and delivery strategies. Appl Microbiol Biotechnol 109:247. https:\/\/doi.org\/10.1007\/s00253-025-13620-0","journal-title":"Appl Microbiol Biotechnol"},{"key":"9202_CR369","doi-asserted-by":"publisher","first-page":"e2250348","DOI":"10.1002\/eji.202250348","volume":"54","author":"I Mezghiche","year":"2024","unstructured":"Mezghiche I, Yahia-Cherbal H, Rogge L, Bianchi E (2024) Interleukin 23 receptor: Expression and regulation in immune cells. Eur J Immunol 54:e2250348. https:\/\/doi.org\/10.1002\/eji.202250348","journal-title":"Eur J Immunol"},{"key":"9202_CR370","doi-asserted-by":"publisher","first-page":"112128","DOI":"10.1016\/j.celrep.2023.112128","volume":"42","author":"J Jacobse","year":"2023","unstructured":"Jacobse J, Brown RE, Li J et al (2023) Interleukin-23 receptor signaling impairs the stability and function of colonic regulatory T cells. Cell Rep 42:112128. https:\/\/doi.org\/10.1016\/j.celrep.2023.112128","journal-title":"Cell Rep"},{"key":"9202_CR371","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1007\/s13238-018-0505-z","volume":"9","author":"Y Hou","year":"2018","unstructured":"Hou Y, Zhu L, Tian H et al (2018) IL-23-induced macrophage polarization and its pathological roles in mice with imiquimod-induced psoriasis. Protein Cell 9:1027\u20131038. https:\/\/doi.org\/10.1007\/s13238-018-0505-z","journal-title":"Protein Cell"}],"container-title":["Clinical Reviews in Allergy & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-026-09202-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12016-026-09202-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-026-09202-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:56:46Z","timestamp":1789012606000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12016-026-09202-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":371,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9202"],"URL":"https:\/\/doi.org\/10.1007\/s12016-026-09202-1","relation":{},"ISSN":["1559-0267"],"issn-type":[{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]},"assertion":[{"value":"29 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"75"}}